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ABSTRACT
DEVELOPMENT OF ANALYTICAL METHODS FOR TOXIC INHALED HAZARDS
(TIH) AND THEIR METABOLITES
OBED ADU GYAMFI
2020
Toxic inhalation hazards (TIHs), such as methyl isocyanate (MIC) and hydrogen
cyanide (HCN), are noxious gases and vapors that are harmful, and often deadly, to
humans. However, because of their low cost and high reactivity, they are extensively used
for industrial productions, creating risk of exposure for both industrial workers (e.g.,
occupational exposure) and civilians (e.g., accidental release during transport). The illicit
use of TIHs, including as terrorist agents, is also concerning. Considering the rapid toxicity
of TIHs and the danger they pose to both human and animal lives, there is a critical need
to develop of analytical methods for the analysis of TIH metabolites and therapeutic agents
to verify their exposed and to help in further development of these therapeutics.
One therapeutic strategy for TIH exposure is inhibition of the transient receptor
potential ankyrin 1 (TRPA1) ion channel, since some TIH toxic effects are triggered by
activation of this channel. Antagonists of TRPA1 have shown near complete attenuation
of the noxious effects from TIH exposure. One of the TRPA1 antagonists, A-967079, has
shown impressive efficacy, high selectivity, high potency, and oral bioavailability.
However, no method for its analysis from any matrix is currently available. Hence, a simple
HPLC-MS/MS method was developed and validated to quantify A-967079 in plasma. The
method features an excellent LOD of 25 nM, a wide linear range (0.05–200 μM), and good
accuracy and precision. The method was successfully applied to determine A-967079 from
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treated animals and it may facilitate the development of A-967079 as a therapeutic agent
against the noxious effects of TIH exposure.
While there are a number of known metabolites of cyanide (CN), the interaction of
CN with glutathione has not been explored. Therefore, we studied the interaction of CN
and GSH to identify the novel CN metabolite, 2-aminothiazoline-4-oxoaminoethanioc acid
(ATOEA). The production of ATOEA from cyanide exposure was confirmed by detection
of both ATOEA and ATOEA-13C15N in rabbit plasma (N = 11 animals) following
administration of NaCN:K13C15N (1:1), with a similar amount of ATOEA and ATOEA13 15

C N formed (R2 = 0.9924, p < 0.05). An HPLC–MS/MS method was developed and

validated to analyze ATOEA from plasma, producing a linear range of 0.5–50 μM, a limit
of detection of 200 nM, and excellent precision and accuracy. ATOEA concentrations were
significantly elevated in the plasma of animals following cyanide exposure. Using this
method, we showed that ATOEA is produced from interaction of CN and GSH and can
serve as a biomarker of CN exposure.
A field portable detection method was developed to detect the CN metabolite,
thiocyanate, from fish blood to verify CN-fishing (an illegal fishing technique practice in
Southeast Asia that has detrimental effect on aquatic life). The cyanide sensor was adapted
via oxidation of thiocyanate to cyanide using KMnO4, microdiffusion, reaction of the
cyanide with naphthalene dialdehyde and taurine, and fluorescence analysis of the resulting
β-isoindole product. The method presented here features an excellent LOD (29 µg/L) and
an acceptable linear range (59-590 µg/L), good accuracy (100±20%) and good precision
(<20% relative standard deviation). The method was successfully applied to quantify
thiocyanate from the blood of marine fish exposed to cyanide. The full development of the

xx
proposed sensor would allow rapid field and laboratory analysis of suspected cyanidecaught fish by government, aquarium trade and food agencies to help enforce this illegal
practice.

1
Chapter 1. Introduction
1.1. Overall Significance
Cyanide and other toxic inhalation hazards (i.e., methyl isocyanate (MIC),
chlorine gas, chloroacetophenone, chloropicrin, etc.) have great importance for industries,
including mining, agrochemicals, plastics, and pharmaceuticals. They have also been used
for illicit activities like suicide, homicide, as chemical warfare agents and in illegal fishing
activities (i.e., cyanide-fishing). Use of these chemicals poses severe risk to humans and
the environment. Therefore, there is a critical need to improve ways to monitor the illicit
use of these chemicals, to confirm human exposure to TIHs, and to develop effective
therapeutics agents to battle their toxic effects.
1.2. Project Objectives
This dissertation is comprised of three main objectives: 1) Develop a simple and rapid
analysis technique for the analysis of TRPA1 antagonist, A-967079, in plasma. 2) Identify
novel metabolite of CN, produced by the interaction of CN with glutathione, 3) Develop a
field portable analysis technique to determine SCN in fish blood, in order to monitor CNfishing. Chapter 2 addresses the analysis of TRPA1 antagonist, A-967079; in plasma, using
high-performance liquid chromatography tandem mass-spectrometry. Chapter 3 details the
metabolism of CN by glutathione, to produce the novel CN metabolite, 2-aminothiazoline4-oxoaminoethanoic acid. Chapter 4 describes the analysis of CN metabolite, SCN, in fish
blood via modification of a field-portable CN sensor (i.e., the Cyanalyzer) to monitor CN
fishing. Chapter 5 contains the conclusion and suggested future studies.
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1.3. Toxic Inhalation Hazards
The increase in the world’s population has caused a huge demand on modern
industrial production. These demands have led to the use of easy and cost-effective
manufacturing practices, including the use of small molecule precursor chemicals. Many
of these chemicals are toxic inhalation hazards (TIHs), noxious gases which are toxic to
humans and other organisms.[1-3] The ease of producing these compounds and their lowcost supply, in addition to their high reactivity makes them useful for synthesis of many
industrially important products. They are also used themselves for a number of purposes
including agriculture, mining, cleaning etc.[2, 4] For example, chlorine gas is used for
water treatment, cleaning, antiseptics and chemical synthesis. Ammonia is used in the
production of fertilizers.[4, 5] Methyl isocyanate (MIC), a reactive TIH, is widely use in
the production of pesticides, fungicides and polymers.[6] The mining and the metallurgy
industries employ sodium cyanide in the extraction previous metals and other minerals.[7]
The demand for TIHs poses risk of exposure to industrial workers, custodians, and
farmers. Accidental leaks of TIHs in industries and highly populated areas during
transportation have also injured and kill many.[7-12] TIHs, such as sulfur mustard, chlorine
gas, cyanide, etc., have also been used as chemical warfare agents by many military and
terrorist groups to kill and injure civilian population.[13-16]
Exposure to most of reactive TIHs compromises the respiratory system by causing
severe damage of the airways and lung.[1, 17] Following trace level, reactive TIHs are
perceived as irritating, and induce sneezing, coughing, mucus secretion, tearing, and upper
airway inflammation.[1, 18] These responses help neutralize, and expel these toxins,
limiting damage to alveolar sacs.[19, 20] At higher levels, the noxious responses advanced
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to uncontrollable coughing, profuse lacrimation, resistance to airflow by bronchospasm,
mucus hypersecretion, and upper and lower airway inflammation and compounds
preexisting respiratory condition such as triggering attack on asthmatic individuals.[21, 22]
In severe and prolong exposure, TIHs causes severe lung damage and also damages the
delicate alveolar sacs by reacting with the lung tissues.[23, 24] These physiological
behavioral responses from TIHs are as results of its detection by the olfactory and
nociceptive sensory systems that triggers signals to the brain by activating transient
receptor potential (TRP) and acid-sensitive ion channels.[3, 25, 26]
1.4. TRPA1 ion channel
Transient receptor potential ankyrin 1 (TRPA1) is a member of the superfamily of
transient receptor potential (TRP) ion channel.[27] TRPA1 has a tetrameric structure with
each subunit containing six transmembrane spanning segments (S1-S6), and an
intercellular NH2 and COOH termini domains.[28, 29] In between the S5 and the S6
transmembrane helices domain is a pore-forming loop.[30, 31] TRPA1 also has a large
cysteine and lysine-rich N-terminus that contains 14-18 predicted ankyrin repeats, which
distinguishes it from other TRP ion channels (Fig 1.1).[32-34] TRPA1 is abundantly
expressed in nociceptive neuron of dorsal root ganglion (DRG), jugular ganglia (JG), and
trigeminal ganglion (TG) neurons, which are the main receptors responsible for the noxious
effect response of TIH exposure (Table 1.1).[1] TRPA1 channels expressed on nociceptors
are consider important chemosensors.
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Figure 1.1. Diagram showing the structure of one subunit of TRPA1

Table 1.1. Toxic inhalation hazards and their activating TRPA1 sensory neurons

Type of Chemical

TIH (Toxicant)

Sensory Neuron

Electrophile

Trans-2-pentenal

TG[35]

Electrophile

Toluene diisocyanate

TG[36]

Electrophile

Methyl isocyanate

DRG[3]

Electrophile

Hexamethylene diisocyanate

DRG[3]

Electrophile

Benzyl bromide

DRG[3]

Electrophile

Bromoacetone

DRG[3]

Electrophile

Crotonaldehyde

JG[37]

Electrophile

Acrolein

JG, TG[37]
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Electrophile

Allylisothiocyanate

TG[1]

Electrophile tear gas

Chloroacetophenone

DRG[3]

Electrophile tear gas

Chlorobenzalmalononitrile

DRG[38]

Electrophile tear gas

Dibenzoxazepine

DRG[38]

Electrophile air pollutant

Cigarette smoke extract

JG[37]

Aldehyde

Formalin

DRG[39]

Oxidant

Chlorine

DRG/TG[18]

Oxidant

Hydrogen peroxide

DRG/TG[18, 40]

DRG = dorsal root ganglia, JG = jugular ganglia, TG = trigeminal ganglia

Many types of chemical irritants and pharmacological agents activate TRPA1.
Most especially, TRPA1 is activated many TIH including the reactive oxidizing and
electrophilic chemical species (Table 1.1).[1, 41] TIH activation is initiated by covalent
modification of the TRPA1 by electrophilic bonding (Michael’s Addition) of the reactive
TIH to either the cysteine or the lysine residue of the TRPA1.[32, 33] Reactive TIHs are
detected by peripherals sensory neuron after activating of the TRPA1 ion channel (Table
1.1).[1, 29, 42] The activation of the ion channel following TIH exposure (i.e., electrophilic
modification of TRPA1) induces neurogenic inflammatory and brain-mediated responses
of the airways that lead to hypersensitivity of both the upper and lower airways causing
noxious effects, including immediate unbearable irritation of the eye, nose, and throat,
inducing sneezing, coughing, tearing, mucus secretion, upper airway inflammation, etc.[3,
34, 41, 43, 44]
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The noxious effects cause by the activation of TRPA1 ion channel have led to
scientists targeting this ion channel to develop therapeutics that could alleviate the acute
effects of the lung diseases and disorders associated with reactive TIHs exposure.[17, 41]
Evidence of the importance of this strategy was found when genetically deleted TRPA1
mice showed near complete no noxious effect from the exposure to TIHs. In addition, many
antagonists of TRPA1 have been effective in blocking noxious behavior induced by
neurogenic inflammation.[45, 46]
To date, a few promising TRPA1 antagonists have been reported, including AP18
(IC50 of 3.1 to 6.9 µM), HC-030031 (IC50 of 1 to 41.8 µM) and A-967079 (IC50 of 51 to
289 nM).[39, 47-49] AP18 is selective for TRPA1 over several other TRP channels;
however, it has poor bioavailability through oral and intraperitoneal dosing.[50, 51] HC030031 is bioavailable through various dosing and it is reported to be selective to other
TRP ion channels, however, HC-030031 also inhibits other several pain-signaling
proteins.[47, 52] A-967079 is potent, highly selective, and orally bioavailable TRPA1
antagonist. Unlike other TRP antagonists, A-967079 does not produce locomotor or
cardiovascular side effects and does not have an effect on body temperature.[46, 49, 53]
1.5. History and Uses Cyanide
1.5.1. History and Ancient Use
Cyanide (HCN and CN- are inclusively represented as CN) is known as highly toxic
chemical that can cause death within minutes of exposure and has been used as a poison
for thousands of years.[7, 54, 55] The use of CN dates back to the times of the ancient
Egyptians and Romans, where CN containing plants (e.g., cassava, bitter almonds, cherry
laurel leaves, peach pits, etc.) were used for poisonings and judicial executions.[56-58] In
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1679, Wepfer first described CN poisoning by extraction it from almond.[59] Although
CN containing plants have been used as poison for centuries, Carl Scheele first identified
CN in 1782 by isolating it from Prussian blue dye and further described CN as an acidic
water-soluble flammable gas and named it “prussic acid”.[58, 60] In 1815, Gay-Lussac
definitively determined that the molecular formula of cyanide contained no oxygen, which
disputed the theory that all acids must contain oxygen.[59] He further identified CN as a
gas with an almond-like flavor, which is colorless and poisonous and name it cyanogen.[59,
61, 62]
1.5.2. Military Use
Military use of CN is dated back in the 1870s when Napoleon III ordered the use
of CN as war weapon during the Franco-Prussian war (1870 war).[63] The use of CN as a
chemical warfare agent (CWA) was officially documented during World War I (WWI),
when the French used HCN in 1915. The use of HCN was discontinued by the French
because HCN dispersed rapidly in open air.[58] In late 1916, the French and Austrians used
cyanogen chloride and cyanogen bromide, respectively, to decrease diffusion in open air
because they are less volatile and heavier than HCN.[14, 60] Later, the use of these
derivatives of CN during the WWI was discontinue because they were unstable and
corrosive.[14] During World War II (WWII) the Nazis used HCN (Zyklon B) to kill
millions of civilians and soldiers in gas chambers. It was alleged that the Japans used CN
on China during the WWII. In the 1980s, CN was used during the Iran-Iraq war to kill the
Kurds of Iraq and Syria.[64-66]
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1.5.3. Illicit Use (Cyanide Fishing)
For many centuries, different fishing techniques such as netting, angling, trapping
hand gathering, and spearfishing have been used to harvest fish. Because of low harvesting
yield per unit effort from many of fishing techniques, illegal techniques such as cyanidefishing has been adopted in southeast Asia and many other regions.[67, 68] The use of CN
to capture live fish for the marine aquarium trade was first reported in the Philippines at
1960s.[69, 70] Since then the practice has rapidly spread throughout many countries
including Indonesia, Malaysia, Maldives, Papua New Guinea, Sri Lanka, Thailand,
Vietnam,[71, 72] not only for aquarium trade but also for the live reef fish food trade which
target large-sized groupers, wrasses and coral trout for human consumption.[73, 74] In the
mid-1980s, it was estimated that more than 80% of all fish collected in Philippines for
aquarium trade supply were harvested by CN and in the 1990s, almost 90% of fishing
vessel in the eastern island of Indonesia had CN on board.[75, 76] CN fishing is illegal in
most countries where the technique is practice. About 78% of the 18 main exporting
countries have passed anti-cyanide fishing law to curb this practice. Although it is illegal,
because of the nature of the trade chain involved in this practice, enforcement of these laws
has not been successful and CN-fishing is still commonly practiced today. [74, 77]
CN fishing has led to population decline in moderately abundant target fish species,
including Cheilinus undulates.[78, 79] Also, severe long-term effects on non-targeted
species, including coral and other invertebrates, has been observed.[80] Exposure to very
low concentration of CN causes reduction in respiration resulting in bleaching and eventual
death of corals and anemones.[81, 82] Moreover, CN fishing endangers the fishers
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involved in this practice due to their use of large quantities of cyanide and minimal
protective measures used .[82]
1.6. Source of Cyanide
1.6.1. Natural Sources
CN is present in the environment in a number of forms. The major natural source
of CN is edible plants that contain cyanide as cyanogenic glycosides, which release cyanide
through hydrolysis.[83, 84] Several species (i.e., 800 species) of these edible plants and
fruits have been identify to produce cyanide, including cassava, almonds, sweet potatoes,
yams, peaches, apple, pears, sorghum, etc.[83, 85] Microorganisms (i.e., algae, bacteria
and fungi) and several species of arthropod and insects such as centipedes, millipedes,
moths, butterflies and beetles synthesize and excrete cyanide as a self-defense
mechanism.[83, 86, 87] Volcanic eruptions can release HCN into the atmosphere by carried
ash leading to the potential contamination of the air and nearby water.[88] The abundance
of cyanogenic plants, insects, and microorganisms pose risk of cyanide exposure to people
including survivalist, nature enthusiasts, farmers, and ranchers. Therefore, caution should
be taken when choosing the type of plants and insects they eat, grow or touch to keep them
from accidental cyanide exposure.
1.6.2. Anthropogenic Sources
Currently, anthropogenic exposure to CN occurs through industrial operations,
metal extraction, fire/smoke inhalation, chemical synthesis, etc.[89, 90] About 1.4 million
tons of CN is estimate to be produced annually.[89] HCN, the gaseous form of CN, is
produced by three main processes, namely Andrussow, Degussa, and Shawinigan.[91-93]
The Andrussow process utilizes reaction of methane and ammonia to produce HCN in the
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presence of oxygen and a platinum catalyst.[92] The Degussa process of producing HCN
also involves reaction of methane and ammonia to produce HCN using platinum as a
catalyst, but does not utilize oxygen.[93] In the Shawinigan Process, HCN is produced by
the reaction of ammonia and propane gas in the presence of coke.[94] CN salts (i.e., NaCN
and KCN) are produce by reacting of HCN with the respective alkali metal. Extraction of
precious metals such as gold, silver, zinc, etc. from their ore is one of the major uses of
CN, due to CN strong binding capacity to these metals.[7, 61] In addition to its use to
extract metals, CN is also used in the synthesis of pharmaceuticals, pesticides, dyes, fibers
and polymers and pigments. Due to the large production CN and its extensive use in
industry, there is an increased risk of occupational CN exposure.
Although occupation exposure to CN is alarming, smoke inhalation from household
or industrial fires and cigarette smoke is the leading source of exposure.[95, 96] The
production of HCN from cigarettes ranges from 10-400 μg/cigarette and the amount in
secondhand smoke ranges from 0.006-0.27 μg/cigarette.[90] Another source of CNcontaining smoke is the incomplete combustion of nitrogen-containing materials and
compounds such as plastic, wool, silk, nylon, melamine and polyurethane.[96] Reports
have shown that victims of fire accidents may have been exposure to both carbon monoxide
(CO) and CN, and majority of the death resulting from these incidence are attributed to
CN-poisoning.[55, 96]
1.7. Toxicity of Cyanide
The onset of CN exposure is rapid (i.e., symptoms can occur in as little as 15
seconds) and death may occur within minutes depending upon the level and route of
exposure.[7, 59] A blood concentration of 19 μM is considered toxic, and it could be
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considered fatal at blood concentrations greater than 115 μM.[97, 98] The primary effect
of CN toxicity is the impairment of oxidative phosphorylation, a process whereby oxygen
is utilized for production of ATP, an essential cellular energy source.[60, 99] This process
involves the transfer of electrons from NADH to oxygen through a series of electron
transfer steps. This process is catalyzed by cytochrome c oxidase enzyme, found in
complex IV of the electron transport chain (Figure 1.2).[100-102] Upon exposure, CN
inhibits cytochrome c oxidase by binding to Fe3+ found in the heme A3 moiety of the
enzyme, resulting in loss of structure integrity and hence, the effectiveness of the
enzyme.[103] Inhibition of cytochrome c oxidase prevents electron transfer, leading to
impairment of cellular respiration.[96, 104] In addition, the disruption of H+ gradient
ceases the production of ATP. In order to compensate for ATP loss, glucose is broken down
via glycolysis, leading to the production of pyruvate that reduces to lactic acid.[58] As
lactic acid concentration increases in blood, the body pH decreases leading to the
impairment of several physiological processes, ultimately leading to cell death.[58, 89,
105]
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Figure 1.2. Diagram showing the inhibition of cytochrome c oxidase within the electron
transport chain in the mitochondrial membrane.[102]
1.8. Metabolism of Cyanide
The strong reactivity and volatility of CN in biological environments leads to
multiple metabolism pathways (Figure 1.3).[106] The most important naturally occurring
CN metabolic pathway is the detoxification CN by a sulfur donor to form the much less
toxic thiocyanate ion (SCN‒),[107] accounting for about 80% of the total CN
metabolism.[60] The two major enzymes that catalyze this process are rhodanese and 3mercaptopyruvate sulfurtransferase.[107-109] An alternative metabolism pathway for CN
is its conversion to 2-amino-2-thiazoline-4-carboxylic acid (ATCA).[60] CN is
metabolized into ATCA by its direct interaction with cysteine in the physiological
environment.[110] This non-enzymatically catalyzed pathway accounts for about 0.109.19% of the total CN detoxification.[55, 111]
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Figure 1.3. Metabolic pathway of cyanide and major ways of release. Diagram adapted
from Logue et al.[111] Thiocyanate ion (SCN‒), 2-amino-2-thiazoline-4-carboxylic acid
(ATCA), 2-iminothiazolidine-4-carboxylic acid (ITCA)
Other minor metabolites of CN exposure have been reported, but information about
them is limited. One of these minor metabolites is α-ketoglutarate cyanohydrin (α-KgCN)
which is formed from the reaction of CN with α-ketoglutarate (α-Kg) in biological
environments.[112-114] The reversible reaction of cyanide with hydroxocobalamin to
form cyanocobalamin is another minor metabolic pathway of CN.[115] CN-protein
adducts, which are formed by the interaction of CN with disulfide bonds in human plasma
proteins, has also been reported.[116]
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Chapter 2. Analysis of Trpa1 Antagonist, A-967079, in Plasma Using HighPerformance Liquid Chromatography Tandem Mass-Spectrometry
2.1. Introduction
Toxic inhalation hazards (TIHs) are noxious gases and vapors (methyl isocyanate
(MIC), chlorine, chloroacetophenone, chloropicrin, etc.) that are harmful and often deadly
when inhaled.[1, 3, 13, 117] However, because of their low cost and ease of manufacture
along with their high toxicity and relatively short half-life, they are used for many purposes,
including fumigation, fungicide, disinfection, pest control, and cleaning. Many TIHs are
also important for metallurgy, plastics, pharmaceuticals, and semiconductors.[1, 2, 6]
Therefore, industrial demand for TIHs, and their transport through highly populated areas,
significantly increases the risk of exposure.[10, 118] The potential use of TIHs by terrorists
to injure and kill civilians is also concerning.[13-16] The risk of TIH exposure is most
infamously illustrated by the tragic accident in Bhopal, India (1984) where more than 8000
people died within few minutes of methyl isocyanate (MIC) exposure.[8, 9]
Many TIHs are detected by olfactory neurons and peripheral sensory neurons by
activating transient receptor potential (TRP) cation channels,[29, 42, 119] and acidsensitive ion channels (ASICs).[25, 26] The activation of these channels, following TIH
exposure, triggers signaling to the brain which leads to immediate unbearable irritation of
the eye, nose, and throat, and induces sneezing, coughing, mucus secretion, upper airway
inflammation, and tearing.[3, 25, 34, 43] At prolonged or high-dose exposure, these
responses progress to severe pain, intense coughing, profuse flow of tears, and resistance
to airflow by bronchospasm, mucus hyper-secretion, and pneumonitis.[1, 41, 44] TRP
ankyrin 1 (TRPA1), a member of the TRP ion channel family expressed on nociceptive
primary afferent C-fibers, is a main receptor for the noxious effect response of TIH
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exposure and is activated by about 40% of all TIHs, including all oxidizing and
electrophilic TIHs (e.g., tear gas agents and MIC).[1, 3, 41, 43] The importance of TRPA1
in TIH response has been shown experimentally with both TRPA1-knockout (Trpa1−/−)
mice and TRPA1 antagonist-treated mice showing complete cessation of the noxious
effects of TIHs.[17, 41, 45, 46, 52]
To date, very few TRPA1 antagonists have entered into pre-clinical trials. The
major setbacks of this therapeutic strategy is a lack of potency, selectivity, and
bioavailability.[50, 120] For example, AP18 (4-(4-Chlorophenyl)-3-methyl-3-buten-2-one
oxime, Fig 2.1) is potent and selective for TRPA1 over other TRP ion channels,[50, 51,
121] but shows poor bioavailability following intraperitoneal and oral administration.
Similarly, HC-030031 (2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N(4-isopropylphenyl)acetamide, Fig 2.1) is also selective for TRPA1 over other TRP
channels, but it has been reported to also inhibit several non-TRP pain signaling
proteins.[47, 52]
The limitations of TRPA1 agonist compounds have necessitated the continued
search for more efficacious antagonists. Recently, (1E,3E)-1-(4-Fluorophenyl)-2-methyl1-pentene-3-one oxime (A-967079, Fig 2.1) has shown impressive efficacy as an
antagonist to TRPA1 and has multiple advantages over other compounds, including high
selectivity, potency, and oral bioavailability.[46, 49] A-967079 has IC50 values of 67 and
289 nM for human and rat TRPA1 receptors, respectively. It displays 1000-fold selectivity
for TRPA1 over other TRP channels, and greater than >150-fold selectivity over 75 other
ion channels, enzymes and G-protein-coupled receptors.[46, 49, 53, 122] Other advantages
of A-967079 including no locomotor or cardiovascular effects, a common side effect of
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other TRP antagonists. Oral administration of A-967079 in rats produced robust
bioavailability and analgesic efficacy for TIH-induced pain response (i.e., sneezing,
tearing, coughing, etc.) and osteoarthritic pain.[49, 122] Intravenous injection of A-967079
has also shown to decrease the reactive gas response of wide dynamic range (WDR, i.e. to
about 61% from baseline levels in rat) and pain specific-neurons.[46, 122]
In spite of the potential advantages of A-967079, there is no currently available
validated analytical method for its quantification. Therefore, the objective of this study was
to develop and validate a high-performance liquid chromatography tandem mass
spectrometry (HPLC-MS/MS) method for the analysis of A-967079 in plasma, which can
be used in further development of A-967079 as a countermeasure for TIH exposure.

Figure 2.1. Chemical structures of TRPA1 antagonists with their respective identification.
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2.2. Materials and Methods
2.2.1. Materials
All reagents and solvents were at least HPLC grade, unless otherwise specified.
Ammonium formate was obtained from Sigma-Aldrich (St. Louis, MO, USA). Acetone,
ethanol, and methanol (LC–MS grade) were purchased from Fisher Scientific
(HanoverPark, IL, USA). A-967079 (>98% purity), supplied by Dr. Carl W. White
(Pediatrics-Pulmonary Medicine, University of Colorado-Denver, Denver, CO, USA), was
purchased from Med Chem 101 (Plymouth Meeting, PA, USA; 98% Purity; Lot X101075).
Polymeric reversed phase column, PLRP-S 300Å (50 × 2.1 mm, 3.0 μm, part #:PL19121301) was purchased from Agilent (Santa Clara, CA 95051). Water was purified to 18.2
MΩ-cm by reverse osmosis using a Lab Pro polishing unit from Labconco (Kansas City,
KS, USA). A-967079 was dissolved in ethanol:water (1:1) to make a stock solution of 10
mM concentration, which was further diluted to 5 mM in mobile phase A (pH~4), and
stored at 4 °C. The stock solution of A-967079 (5 mM, in mobile phase A) was further
diluted to 0.025‒500 µM with either mobile phase A or plasma to produce working
standard solutions.
2.2.2. Biological Samples
For analytical method development and validation, rabbit plasma (non-sterile with
EDTA) was purchased from Pel-Freeze Biologicals and was stored at -80 °C until used.
Rabbit plasma was used to develop the method presented here because we planned to
utilize a rabbit model developed by our collaborators to prove the applicability of the
analytical method for the analysis of A-967079 concentrations plasma. However, at the
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time we were finalizing the method validation, efficacy studies of A-967079 were
transitioned to a rat model. Plasma samples from A-967079-treated male Sprague-Dawley
rats were obtained from the Pediatrics-Pulmonary Medicine, University of ColoradoDenver, Denver, CO, USA. Rats (250–350 g) were separated into eight groups (n=3 for
each group) and each group was intraperitoneally administered 100 mg/kg A-967079 in
5% DMSO/sesame oil. Animals from groups 1‒8 were euthanized at 0.25, 0.5, 1, 1.5, 2, 4,
8, and 24 h post-treatment, respectively, and blood was collected. Another group (n=3) was
euthanized without A-967079 treatment and blood was collected as control (blank).
Collected blood was placed in clean plastic tubes with EDTA anti-coagulant and
centrifuged to separate the plasma from erythrocytes. Plasma was then transferred to a
clean centrifuge tube, flash frozen, and shipped on dry ice (overnight) to South Dakota
State University. Upon receipt, the plasma was stored at -80 °C until analysis was
performed. All animals were cared for in compliance with the “Principles of Laboratory
Animal Care’’ formulated by National Society for Medical Research and the “Guide for
the Care and Use of Laboratory Animals” prepared by the National Institutes of Health.
The University of Colorado-Denver and Institutional Animal Care and Use Committee
(IACUC) approved the animal study.
2.2.3. Sample preparation for HPLC-MS/MS analysis
Plasma (100 µL) was added to a 2-mL centrifuge tube. Acetone (300 µL) was added
to the plasma to precipitate proteins. The sample was vortexed for about 3 min, and then
cold centrifuged (8 °C) at 10,000 rpm (12,300 × g) for 5 minutes. An aliquot (300 μL) of
the supernatant was transferred into a 4-mL glass screw-top vial and evaporated to dryness
(at room temperature) using nitrogen. The contents of the glass vial were then reconstituted
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with 100 µL of 0.1% ammonium formate in water (pH ~4). The solution was thoroughly
mixed, filtered using a 0.22-µm tetrafluoropolyethylene membrane syringe filter, and
transferred into an HPLC vial with glass insert (100 µL) for analysis.
2.2.4. HPLC-MS/MS Analysis
Liquid chromatography was performed on a Shimadzu HPLC (LC-20AD,
Shimadzu Corp., Kyoto, Japan). The chromatographic separation was performed on an
Agilent polymeric reversed phase column, PLRP-S 300Å (50 × 2.1 mm, 3.0 μm) protected
by a guard cartridge with column temperature maintained at 40°C. Mobile phase A was
0.1% ammonium formate in water and mobile phase B was 0.1% ammonium formate in
methanol, both with a pH of 4. The chromatographic separation was achieved using
gradient elution at a flow rate of 0.35 mL/min as 20% B held constant for 2 minutes,
increased linearly to 100% over another 2 minutes, held constant for 2 minutes, decreased
to 20% B over 2 minutes, and held constant for 2 minutes to equilibrate between injections.
A volume of 10 µL was injected for HPLC-MS/MS analysis.
A tandem mass spectrometer (AB Sciex Q-Trap 5500 MS) equipped with an
electrospray ionization interface operating in the positive polarity was used to detect the
A-967079. The mass spectrometric conditions were optimized by directly infusing A967079 standard solution into mass spectrometer at a flow rate of 10 µL/min where A967079 (m/z = 207), as an oxime, undergoes Beckmann rearrangement under acidic
conditions to gain two protons to form its precursor A-967079 (m/z = 209).[123-125]
Nitrogen (50 psi) was used as both the curtain and nebulization gas. The ion spray voltage
and source temperature were 4,500 V and 500 °C, respectively with both nebulizer (GS1)
and heater (GS2) gas pressures at 90 psi. The collision cell was operated with an entrance
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potential of 10.0 V and a collision cell exit potential of 11.0 V at a medium collision gas
flow rate. A-967079 was analyzed in multiple reactions monitoring mode (MRM) and the
chromatograms were acquired with the Analyst software program. The MS/MS operating
parameters and MRM transitions are listed in Table 2.1.

Table 2.1. MRM transitions, optimized collision energies (CEs), and declustering
potentials (DPs) for the detecting of A-967079 by MS–MS analysis.
Compounds

Q1 (m/z)

Q3 (m/z)

Time (ms) CE (V)

DP (V)

A-967079 (identification)

209

191

100

13.37

116.93

A-967079 (quantification)

209

162

100

46.97

46.97

2.2.5. Calibration, quantification, and limit of detection
The developed analytical method was validated using the Food and Drug
Administration (FDA) bioanalytical method validation guidelines.[126, 127] To determine
the limit of detection (LOD), multiple concentrations of A-967079 were prepared in plasma
and analyzed by HPLC-MS/MS. The LOD was defined as the lowest concentration of A967079 that reproducibly produced a signal-to-noise (S/N) of 3. The noise was determined
as peak-to-peak noise in the blank samples over the elution time of A-967079.
For the calibrators, a working standard of A-967079 was prepared in rabbit plasma.
From the working solution, calibration standards of A-967079 with concentration range of
0.025‒500 μM (0.025, 0.05, 0.1, 0.2, 0.3, 0.5, 1, 3, 5, 10, 30, 50, 100, 200 and 500 μM)
were prepared in rabbit plasma. All calibration standards were analyze in triplicate. The
average peak areas were plotted as a function of A-967079 concentration in plasma to
obtain the linearity, accuracy, and precision of the calibration standards. Both non-
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weighted and weighted (1/x and 1/x2) calibration curves were constructed using linear least
squares and calibrator accuracy was used to determine the best model for quantification.
The lower limit of quantification (LLOQ) and upper limit of quantification (ULOQ) were
defined as satisfying the inclusion criteria of <15% relative standard deviation (RSD, as a
measure of precision), and a percent error (as a measure of accuracy) of 100±20% backcalculated from the nominal concentration for all calibration standards within the linear
range. The goodness-of-fit of the calibration curves was determined using percent residual
accuracy (PRA) (i.e., PRA values ≥ 90% are indicative of a good fit).[128, 129]
The accuracy and precision of the method were evaluated by analyzing three
different quality control (QC) standards, 2 μM (low QC), 20 μM (medium QC), and 60 μM
(high QC), not included in the calibration curve. QCs were analyzed in quintuplicate over
three days (within 7 calendar days). Intraassay precision and accuracy were calculated for
each individual day, and interassay precision and accuracy were calculated from
comparison of the data gathered over three separate days.
2.2.6. Recovery, matrix effect and stability
The assay recovery of A-967079 was determined by the analysis of low, medium
and high QC standards from spiked plasma as a ratio of the same concentration of QCs
spiked in water. Recovery (i.e., signal recovery) was determined as a percentage of the
ratio of the analyte peak areas from spiked plasma which underwent the sample preparation
procedure listed above to the peak areas of dried aqueous QC standards reconstituted in
Mobile Phase A which contained the amount of A-967079 corresponding to 100%
recovery. The matrix effect was determined by creating calibration curves in both aqueous
and plasma matrices, and comparing their slopes. A slope ratio (plasma slope/aqueous
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slope) from the calibration curves greater than one indicates enhancement of the analyte in
plasma, whereas slope ratio less than one indicates suppression of the analyte signal by
plasma matrix.
The short- and long-term storage stability of A-967079 was evaluated by analyzing
plasma spiked with high and low QCs stored at different temperatures at multiple storage
times. The stability (i.e., signal stability) of A-967079 was determined as a percentage of
the initial signal. A-967079 was considered stable in plasma at a specific temperature if the
signal was within 15% of the initial signal. Short-term stability of the QCs was assessed
for 24-h both in the autosampler (at 15 °C) and on the benchtop (at room temperature).
Freeze-thaw stability was evaluated over three freeze-thaw cycles where four different sets
of both low and high QCs were prepared. One set of both QCs was analyzed in triplicate
on the same day, while the other sets were stored at -80 °C. For each cycle, all QC standards
were thawed unassisted at room temperature. One set of the thawed QCs was analyzed in
triplicate as first cycle. The remaining two sets of QCs were again stored at -80 °C. This
procedure was repeated twice more to evaluate the remaining two freeze-thaw cycles. For
the long-term stability studies, QC standards were stored at various storage conditions (80, -30, and 4 °C) and analyzed over 30 days (0, 1, 3, 5 10, 20, and 30 days).
2.2.7. Pharmacokinetic Analysis
Pharmacokinetics parameters were determined using the plasma concentration
data. The first order rate constants (k) associated with both distribution phase (kdis), and
elimination phase (kel) of the curve were estimated via linear regression of the log plasma
A-967079 concentration-time curve. The plasma distribution half-life (t1/2,dis) and
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elimination half-life (t1/2,el) were calculated using natural logarithm (2)/k. The area under
the plasma A-967079 concentration-time curve was calculated by trapezoidal rule.
2.3. Results and Discussion
2.3.1. HPLC-MS-MS Analysis of A-967079
The analytical method for A-967079 from plasma reported here features a rapid and
simple one-pot sample preparation method, consisting of protein precipitation,
centrifugation, and transfer and drying of the supernatant and subsequent reconstitution in
aqueous mobile phase for HPLC-MS/MS analysis. The overall sample preparation time
was less than 20 min, with the total chromatographic analysis time of 10 min (including
equilibration following sample analysis). The ESI(+)-MS of A-967079 ([M·]+ = 209 m/z),
with corresponding proposed assignments of fragments is shown Figure 2.2. Transitions
209→162 and 209→191 m/z were used for quantification and identification of A-967079,
respectively. The optimized DPs and CEs for quantification and identification of A-967079
are shown in Table 2.1.
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Figure 2.2. Representative ESI(+) mass spectra of A-967079 and identification of the
abundant ions. A-967079 (207 Da) undergoes Beckmann rearrangement to produce a 209
Da product.
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Figure 2.3. Representative HPLC-MS/MS chromatograms of spiked (5 μM) and nonspiked A-967079 in rabbit plasma. The chromatograms represent signal response to the
MRM transitions of A-967079 (209 → 191 and 209 → 162 m/z).
Representative HPLC-MS/MS chromatograms of the A-967079 analyzed from
spiked plasma are shown in Figure 2.3. Although the sample preparation protocol was
simple, the method produced excellent selectivity. The A-967079 showed a sharp peak
eluting at approximately 5.2 min, which was completely resolved from other components
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in the matrix. Although the A-967079 peak tailed slightly (As= 1.80), the tailing did not
affect quantification of A-967079.
2.3.2. Linear range, calibration and limit of detection
Standard curves were constructed over the concentration range of 0.025‒500 μM
A-967079 in rabbit plasma. The 0.025 and 500 μM calibrators were outside the linear range
based on the accuracy and precision criteria. Therefore, the linear range of the method was
0.5 μM (LLOQ) to 200 μM (ULOQ) as best described by 1/x2 weighted linear regression.
The linear range of the method was large, spanning over three orders of magnitude, which
is excellent for bioanalytical HPLC-MS/MS methods[127, 130] and should be very useful
for studies were analysis of a wide range of A-967079 concentrations is necessary. The
calibration curves were found to be stable over three days as determined by consistency of
the calculated slopes and the excellent fit of the data over the entire linear range for each
day, as defined by the PRA (Table 2.2). Moreover, the method showed an excellent LOD
of 25 nM in plasma as validated by analysis of multiple A-967079-spiked samples below
the LLOQ over a 3-day period.

Table 2.2. Linear equations, coeﬃcients of determination (R2), and percent residual
accuracy (PRA) for calibration curves created over 3 days.
Day

Equation

R2

PRA(%)

1

y = 1.24e5x – 926

0.9867

95

2

y = 1.24e5x – 1021

0.9974

94

3

y = 1.24e5x – 1296

0.9962

92
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2.3.3. Accuracy and precision
The accuracy and precision of the method were estimated by quintuplicate analysis
of low, medium and high QCs on three different days (Table 2.3). The intraassay and
interassay accuracies were both 100±10.5% of the nominal QC concentrations,
respectively. The precision of the method was good, with all QCs producing %RSDs
<15%. The accuracy and the precision of the method were within the FDA-acceptable
range for method validation from a biological matrix.[127, 129, 130]

Table 2.3. The intra- and interassay accuracies and precisions of A-967079 analysis from
spiked rabbit plasma by HPLC-MS/MS.
Intraassay

a

Interassay

Conc

Accuracy (%)

(µM)

Day 1

Day 2

Day 3

Precision (%RSD)

Accuracy Precision

Day

Day

Day

(%)a

(%RSD)a

1

2

3
<14.2

0.75

100±7.8 100±6.2 100±3.8

14.2

4.3

11.3

100±7.8

7.5

100±6.2 100±3.5 100±10.5

10.8

5.1

9.5

100±10.5 <10.5
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100±8.2 100±1.8 100±8.3

7.5

6.3

6.8

100±8.3

<7.5

Aggregate of three days of QC method validation (n = 15)

2.3.4. Matrix effect, recovery and stability
To determine the effect of the plasma matrix on the analysis of A-967079, the
slopes of standard curves of A-967079 spiked in aqueous and plasma solutions were
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compared. The plasma to aqueous standard curve slope ratio was approximately 0.24,
showing about 76% of suppression of A-967079 signals via the current method. The
recoveries for low, medium, and high QCs of A-967079 from plasma were 22%, 23%, and
26% respectively. Since the % recovery value is the combination of matrix effect and
recovery, the 24% average recovery is likely due exclusively to the 76% matrix effect
suppression of A-967079 signals in rabbit plasma. Although there is a strong matrix effect,
it was extremely consistent, and therefore, did not affect quantification of the A-967079. If
desired, the signal suppression could be corrected via an internal standard, but over the
course of method development, the consistency and accuracy of quantification of A967079 via the method allowed for external standardization.
For the benchtop stability, A-967079 was stable for 10 h in plasma and started
degrading below 85% of the control. Furthermore, A-967079 showed excellent stability,
with not more than 15% deviation from the control, in plasma (-80 °C) over three freezethaw cycles evaluated. Moreover, the prepared A-967079 plasma samples were stable for
24 h in the autosampler, with each signal at least 85% of the initial signal. The long-term
stability of A-967079 was evaluated at multiple temperatures. It was stable for 10 days at
4 °C and showed excellent stability (i.e., not more than 15% deviation from the control) in
plasma at both -30 °C and -80 °C for 30 days. From the results of the stability studies, we
recommend that when storage is necessary, plasma samples should be stored at either -30
°C or -80 °C, and can be thawed and refrozen 3 times for analysis. If samples are to be
analyzed within 10 days, they can be stored at 4 °C.
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Figure 2.4. HPLC-MS/MS chromatogram from the plasma of A-967079-treated rats and
rat plasma obtained prior to A-967079 treatment. The chromatograms represent signal
response to MRM quantification transition of A-967079 (209 → 162 m/z).
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Figure 2.5. Plasma concentration-time pharmacokinetic profile of A-967079 following
intravenous administration of A-967079 to rats. Error bars represent standard error of the
mean (SEM, n=3). Inset: Representation of elimination constant (Kel) of A-967079 by log
concentration-time graph.

2.3.5. Method application and pharmacokinetics
The validated method was applied to the analysis of plasma from rats treated with
A-967079. Chromatograms from HPLC-MS/MS analysis of plasma of rats treated with A967079 and rat plasma obtained prior to treatment are shown in Figure 2.4. In the plasma
of treated rats, A-967079 was elevated as a prominent peak eluting at 5.20 min, whereas
no peak was present in the plasma obtained from rats prior to A-967079 treatment. This
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result confirmed the applicability of the method to analyze A-967079-treated animals, and
further verified the selectivity of the method.
The pharmacokinetic profile of A-967079 for a single dose in rats is shown in
Figure 2.5 with pharmacokinetic parameters listed in Table 2.4. The profile shows a rapid
increase and subsequent quick decrease in A-967079 concentration, with a Cmax and tmax of
26.6 µM and 1.50 h, respectively. The distribution half-life (t1/2,dis) and distribution
constant (Kdis) were 1.8 h and 0.3943 h-1, respectively. These results show that A-967079
is quickly absorbed and distributed in the rat. Elimination was slower, with a t1/2,el of 9.76
h. The large area under the curve (i.e., AUC=56.3 µM*h) along with relatively slow
elimination of A-967079 indicate the relatively slow clearance. This suggests that A967079 may have the ability to treat victims of TIH exposure for extended periods
following treatment.
Table 2.4. Pharmacokinetic parameters of A-967079 in a rat.
Cmax (µM)

t1/2,dis (h)

t1/2,el (h)

Kdis (h-1)

Kel (h-1)

AUC (µM*h)

26.60

1.757

9.76

0.3943

0.0710

56.30

2.4. Conclusion
A simple and sensitive HPLC-MS/MS method for the determination of A-967079
in plasma was developed. The method presented here is the first validated method for the
detection of A-967079 in any matrix. The method features simple sample preparation, rapid
analysis, an excellent detection limit, and a wide linear range of 0.05‒200 μM (i.e., covered
over 3 orders of magnitude). The method presented has the ability to analyze A-967079
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from plasma of treated animals, which will allow further drug development of A-967079
as therapy for pain and other noxious effects from TIH exposure.
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Chapter 3. Metabolism of Cyanide by Glutathione To Produce The Novel Cyanide
Metabolite, 2-Aminothiazoline-4-Oxoaminoethanoic Acid
3.1. Introduction
Exposure to cyanide (HCN or CN-, inclusively represented as CN) can occur by the
consumption of foods that contain cyanogenic glycosides (e.g., almonds),[131, 132] and
from the use of CN in electroplating, plastic production, synthesis of pesticides, and mining
(extraction of gold and silver).[55] Other sources of exposure include smoke from
cigarettes, fires, vehicles, and the use of CN in homicides, suicides or terrorist
activities.[95, 133-135] The toxic effects of CN are rapid and can lead to death. Therefore,
the confirmation of CN exposure is important for forensic and diagnostic
applications.[136] Confirmation of cyanide exposure can be accomplished by detection of
either protonated (HCN, pKa = 9.2) or non-protonated (CN-) forms of CN,[137] where
HCN is highly volatile and CN- is a strong nucleophile.[55, 138] Although direct analysis
is the most straightforward way to verify CN exposure, CN is relatively quickly eliminated
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from biological fluids (t1/2 = 0.34-1.0 h in biological fluids) due to its volatility and
reactivity. Therefore, confirmation of CN exposure through direct analysis is unreliable in
many circumstances, especially after a relatively long period of time has elapsed.[111]
These limitations have led to the exploration of more stable markers to confirm CN
exposure.
Free thiocyanate (SCN-) is the major metabolite of cyanide, formed from the
reaction of cyanide with sulfur donors in the presence of rhodanese (Figure 3.1.).[107] Due
to its longer half-life in biological fluids,[55, 113] thiocyanate is a longer-lived marker for
cyanide exposure. However, thiocyanate has limitations as a marker to confirm cyanide
exposure.[106, 138] Ballantyne reported a low recovery of thiocyanate and concentration
instability during various storage conditions in whole blood.[139] Furthermore, edibles like
broccoli, cauliflower and cabbage are known to contain significant amounts of
thiocyanate.[140, 141] Thiocyanate can also be formed by metabolism of other compounds
beside cyanide.[132] These issues contribute to the large and variable background
thiocyanate concentrations in biological fluids (i.e., average SCN− concentrations are
approximately 30.9 ± 13 μM, 130.2 ± 55 μM, and 568.0 ± 128 μM, for blood, urine, and
saliva, respectively),[55, 136] rendering the analysis of free thiocyanate to confirm CN
exposure inconsistent.
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Figure 3.1. Current metabolic pathway of cyanide and major ways of release. Diagram
adapted from Logue et al.[111] Pyroglutamic acid (PGA), 2-amino-2-thiazoline-4carboxylic acid (ATCA), 2-iminothiazolidine-4-carboxylic acid (ITCA), 2aminothiazoline-4-oxoaminoethanoic
acid
(ATOEA),
2-iminothiazolidine-4oxoaminoethanoic acid (ITOEA), and glutathione (GSH).
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The conversion of CN to 2-amino-2-thiazoline-4-carboxylic acid (ATCA) by the
reaction of cyanide with cysteine, as shown in Figure 3.1, is an alternative metabolism
pathway for CN.[77, 138] The reaction of CN with cysteine leads to the formation of
ATCA, and its tautomeric form, 2-iminothiazolidine-4-carboxylic acid (ITCA) (Figure
3.1).[110] ATCA (ITCA and ATCA are referred to inclusively as ATCA) is formed in the
physiological environment by direct interaction of cyanide with cysteine. Moreover,
ATCA is not formed from other known processes,[136] does not metabolize further after
its formation,[77, 138, 142] and it is highly stable in biological samples (i.e., ATCA has
been shown to be stable for months under various storage conditions).[110, 111] However,
Petrikovics et al.[143] reported that, at sublethal doses of CN, the concentration of ATCA
in plasma does not increase significantly, suggesting that ATCA might not be a good
biomarker for sublethal cyanide exposure. Conversely, Bhandari et al,[89] reported that
ATCA concentrations generally followed CN concentrations (i.e., quick elimination in
three animal species and that only a very small amount of ATCA was formed) for sublethal
doses of ATCA. While ATCA may not be a good marker for diagnosis because of its low
abundance and relatively short half-life, its stability makes it extremely promising for
forensic purposes (i.e., post-mortem verification of cyanide exposure).[144, 145]A number
of other markers of CN exposure have been discovered, but information is limited for these
markers. CN reacts with α-ketoglutarate (α-Kg) in biological environments to form αketoglutarate cyanohydrin (α-KgCN).[113, 114] The studies by Mitchell et al.[112, 146]
reported α-KgCN absorption and elimination kinetics were similar to CN and ATCA. Also,
low recovery and poor stability of α-KgCN was demonstrated at various storage conditions
except for −80◦C, where it was stable for 30 days. The reversible reaction of cyanide with
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hydroxocobalamin to form cyanocobalamin is another important metabolic pathway of
CN.[115] Although cyanocobalamin is a promising marker, hydroxocobalamin, a
precursor of cyanocobalamin, is an antidote for cyanide poisoning which would convolute
detection when this antidote is delivered.[147, 148] Also equilibrium between
hydroxocobalamin and cyanocobalamin causing concentration instability and the photodegradability of cyanocobalamin[149, 150] limits its use as a marker to confirm cyanide
exposure. In 2007, Fasco et al.[116] discovered cyanide-protein adducts (formed by the
interaction of CN with disulfide bonds in proteins) in human plasma proteins. Others also
confirmed the presence of these markers following CN exposure.[151, 152] Because many
proteins have long half-lives (e.g., 25 days for albumin and 55 days for hemoglobin),[16,
153] the analysis of cyanide protein adducts may be an excellent forensic marker for
confirming cyanide exposure, but little information is currently available on the usefulness
of these adducts. Because of the limitations of each marker of CN exposure, other markers
of CN exposure may address the disadvantages of the currently known markers.
The affinity of CN for biological thiols, as observed with the production of SCN-,
ATCA, and protein-adducts, likely indicates CN also reacts with other sulfur containing
molecules

such

as

glutathione.

Glutathione

(GSH;

(2S)-2-amino-4-[[(1R)-

[(carboxymethyl) carbamoyl]-2-sulfanylethyl] carbamonyl] butanoic acid) is a ubiquitous
tripeptide in mammals and is an excellent antioxidant. GSH molecules are kept in a reduced
state in animal cells, where its intracellular concentration can be as high as 10 mM. GSH
reduces any disulfide bond formed within cytoplasmic proteins to cysteine by acting as an
electron donor. In the process, GSH is converted to its oxidized form, glutathione disulfide
(GSSG).[154, 155] The detoxification of cyanide with GSH or GSSG may be a first-line
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defense against cyanide intoxication, as studies have demonstrated a reduced toxicity of
cyanide in glutathione and glutathione-disulfide-pretreated mice.[156] Although the
mechanism of reduced toxicity is unknown, it is likely that CN is converted to a less-toxic
compound based on its interaction with GSH. Supporting this hypothesis is a study by
Okafor et al.[157, 158] who studied the effects of CN generated by cassava (i.e.,
cyanogenic glycosides in cassava can produce a large concentration of CN) on endogenous
GSH in rats, and reported a reduction in glutathione concentration in rats fed with cassava.
The objective of this study was to investigate the interaction of cyanide with
glutathione with structural identification of biomarkers of cyanide exposure. A secondary
objective was to develop an analytical method to quantify this biomarker. A tertiary
objective was to evaluate the toxicokinetics of this marker.
3.2. Materials and Methods
3.2.1. Materials
All reagents were high-performance liquid-chromatography (HPLC) grade.
Acetone and methanol were obtained from Fisher Scientific (Hanover Park, IL, USA).
Reduced glutathione, oxidized glutathione, pyroglutamic acid, and ammonium formate
were supplied by Sigma-Aldrich (St. Louis, MO, USA). Cyanamide (NH2CN) was
purchased from Acros Organic (Morris Plains, NJ, USA). Isotopically-labeled cyanamide
(15NH213C15N) was obtained from Cambridge Isotope Laboratories (Andover, MA, USA).
Water was purified to 18 MΩ-cm using a Water PRO PS polisher (Labconco, Kansas City,
KS, USA). All stock solutions were stored at 4 °C. Working ATOEA solutions were
obtained from stock solutions of ATOEA (2 mM) or ATOEA-13C15N (1 mM) via serial
dilutions to the desired concentration.
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3.2.2. Synthesis of ATOEA and ATOEA-13C15N
The proposed reaction scheme for the synthesis of ATOEA is shown in Figure 3.1.
The synthesis of ATOEA was achieved by the modification of Nagasawa et al.[60] method
for the synthesis of ATCA. Cyanamide (NH2CN, 1.77 g, 41.2 mmol) was added to Lglutathione (GSH) (dissolved in 100 mL of H2O, 12.70 g, 41.3 mmol) with stirring. The
resulting clear solution was heated by refluxing under a continuous stream of nitrogen gas
until the pH of the entrained gas dropped from 11 to about 8 (as measured by wetted pH
indicator paper). The reaction mixture was stirred overnight at room temperature, and then
concentrated on a rotary evaporator until a white sticky product formed. Following
overnight refrigeration, the solid was collected, recrystallized from ethanol/H2O (5:1), and
the product was dried in a vacuum desiccator over phosphorus pentoxide (P4O10) to yield
approximately 43% ATOEA. Characterization was achieved by 1H-NMR Spectroscopy
along with ESI-MS operated in positive polarity mode.1H-NMR (D2O, 400 MHz) δ 1.1 (td,
2H) 3.5-3.6 (m, 2H) 3.7 (s, 2H) 3.85 (t, 1H). ESI (+)-MS: m/z 158.0, 101.0, 74.2, 59.0. An
isotopically labeled standard, ATOEA-13C15N was synthesized as described above for
ATOEA, with NH2CN replaced with

15

NH213C15N. ESI (+)-MS: m/z 160.1, 103.0, 74.1,

59.0.
3.2.3. Biological Samples
Rabbit plasma (ethylenediaminetetraacetic acid anti-coagulant) for analytical
method development was purchased from Pel-Freeze Biologicals and stored at -80 °C until
used. Plasma from CN-exposed, New Zealand White rabbits was obtained from the
University of California, Irvine. In one experiment rabbits (N = 8) were infused
intravenously with 20 mg of NaCN in 60 mL of 0.9% NaCl at continuous rate of 1 mL/min
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until apnea. Blood samples were drawn prior to infusion to establish a baseline. Blood
samples were also drawn at 15, 25, 35 min following initiation of CN exposure, apnea, and
5, 7.5, 10, 15, 30 min post-apnea (without administration of antidote). In another
experiment, stable isotope labeled CN was used to confirm the production of ATOEA from
CN. Rabbits (N = 11) were administered lethal doses of 10 mg NaCN (50%) and 13.7 mg
K13C15N (50%) in 60 mL of 0.9% NaCl (1 mL/min continuous intravenous infusion) and
blood samples were drawn prior to exposure (baseline), and 15, 25, and 35 min following
initiation of cyanide infusion. A blood sample was also drawn at apnea. Glyoxylate (200
mg in 2 mL of 0.9% NaCl) was administered as an antidote and blood samples were drawn
at 5, 7.5, 10, 15, 25, 30, 60, and 90 min post-administration of antidote.
After blood was drawn from rabbit, it was placed in EDTA tubes, and centrifuged
to separate the plasma. Plasma was then transferred to a clean centrifuge tube, flash frozen,
and shipped on dry ice (overnight) to South Dakota State University for analysis of
ATOEA and ATOEA-13C15N. Upon receipt, the plasma was stored at -80 °C until analysis
was performed. All animals were cared for in compliance with the “Principles of
Laboratory Animal Care’’ formulated by National Society for Medical Research and the
“Guide for the Care and Use of Laboratory Animals” prepared by the National Institutes
of Health. The CN exposure study was approved by UCIs and Institutional Animal Care
and Use Committee (IACUC).
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Table 3.1. MRM transitions, optimized declustering potentials (DPs), and collision
energies (CEs) for the detection of ATOEA, ATOEA-13C15N, and PGA by MS–MS
analysis
Compounds

Q1 (m/z)

Q3 (m/z)

Time (ms)

DP (V)

CE (V)

ATOEA (quantitation)

204

101

100

90

26

ATOEA (identification)

204

158

100

116

21.7

206

103

100

95.6

22

206

160

100

94

29.6

130

84

100

56.4

18.3

ATOEA-13C15N
(quantitation)
ATOEA-13C15N
(identification)
PGA (identification)

3.2.4. Sample preparation for HPLC-MS-MS analysis
Plasma samples (100 µL) were analyzed in triplicate. Initially, acetone (400 µL)
was added to precipitate the proteins. The contents were allowed to stand for 5 minutes at
room temperature. The sample was vortexed briefly (<10 s), then cold centrifuged (8 ⁰C)
at 13,200 rpm (16,200 × g) for 10 minutes. An aliquot (300 μL) of the supernatant was
transferred into a 4-mL glass screw-top vial, and nitrogen dried for 10 min at room
temperature. The dried samples were then reconstituted with 200 µL of 1 mM aqueous
ammonium

formate,

and

mixed

thoroughly,

filtered

with

a

0.22-µm

tetrafluoropolyethylene membrane syringe filter, and analyzed using HPLC-MS-MS.
3.2.5. HPLC-MS-MS Analysis
HPLC tandem mass spectrometry (HPLC-MS-MS) was conducted on a Shimadzu
HPLC (LC-20AD, Shimadzu Corp., Kyoto, Japan) coupled to an AB Sciex Q-Trap 5500
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MS. The chromatographic separation was achieved using an Agilent Poroshell 120 C18
(150 × 3.0 mm, 2.7 μm) column. The chromatographic separation was carried out with
mobile phase components of aqueous 1 mM ammonium formate as solvent A and 1 mM
ammonium formate in methanol as solvent B. The sample was stored in a cooled
autosampler (15 ⁰C) and 10 µL was injected. Separation was achieved using gradient
elution at a flow rate of 0.35 mL/min with 20% B held constant for 2 minutes, increased
linearly to 100% over 2 minutes, held constant for 2 minutes, decreased to 20% B over 2
minutes, and held constant for 2 minutes to equilibrate between injections.
ATOEA and PGA were detected using positive polarity electron spray ionization
(ESI)-MS-MS. Standard solutions of ATOEA, ATOEA-13C15N, and PGA were directly
infused (10 μL/min) to determine optimum MRM transitions. After infusion of ATOEA,
ATOEA-13C15N and PGA standard solutions into the ESI, molecular ions of m/z 204
([M+1]+), m/z 206 ([M+1]+), and m/z 130 ([M+1]+) respectively, were identified. The most
abundant product ions of ATOEA, ATOEA-13C15N, and PGA are listed in Table 3.1.
Nitrogen gas (50 psi) was used as the curtain and nebulization gas. The ion spray voltage
and temperature source were 4,500 V and 500 °C with both nebulizer (GS1) and heater
(GS2) gas pressures at 90 psi. The collision cell was operated with an entrance potential of
10.0 V and a collision potential of 11.0 V at a medium collision gas flow rate. The total
mass spectrometry acquisition time was 5 min. ATOEA, ATOEA-13C15N, and PGA were
analyzed in multiple reaction monitoring (MRM) mode via the parameters outlined in
Table 3.1.
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Figure 3.2. Proposed scheme for the synthesis of ATOEA (with pyroglutamic acid as a
byproduct) from the reaction of GSH with NH2CN. GSH is proposed to react with NH2CN
to form a GS-CN[116, 159] adduct which likely cyclizes to form ITOEA and glutamic
acid.[116, 160] ITOEA then interconverts to form ATOEA.[60] Glutamic acid then
cyclizes to produce pyroglutamic acid (PGA).[160, 161]

3.2.6. Calibration, quantification, and limit of detection
The validation of the analytical method was achieved by generally following the
FDA bioanalytical method validation guidelines.[126, 130] The lower limit of
quantification (LLOQ) and upper limit of quantification (ULOQ) were defined as
satisfying the inclusion criteria of <15% relative standard deviation (RSD, as a measure of
precision), and a percent deviation within ±20% back-calculated from the nominal
concentration (as a measure of accuracy) for all calibration standards within the linear

COOH
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range. The limit of detection (LOD) was determined by analyzing multiple concentrations
of ATOEA below the LLOQ and determining the lowest concentration which reproducibly
produced a signal-to-noise ratio of at least 3. The percent residual accuracy (PRA) was
used to determine the goodness-of-fit of the calibration curves (i.e., PRA values ≥ 90% are
indicative of a good fit).[128]
From the ATOEA stock solution, calibration standards for ATOEA (0.2, 0.5, 1, 3,
5, 10, 20, 35, 50, 100, 200 and 300 μM) were prepared in rabbit plasma. Following analysis
of the calibration standards, calibration curves were plotted using the peak area of the
analyte (ATOEA) as a function of the ATOEA concentration in plasma. Both weighted
(1/x and 1/x2) and unweighted calibration curves were created using linear least squares. A
weighted 1/x2 fit was chosen as the best model to fit the calibration data.
QC standards (N = 5) were prepared in rabbit plasma at three different concentrations: 0.75
(low QC), 4 (medium QC), and 30 μM (high QC) for ATOEA. The QC standards were
analyzed in quintuplicate each day for 3 days and were run in parallel with the calibration
standards. Intraassay precision and accuracy were calculated from each day’s analysis, and
interassay precision and accuracy were calculated from comparison of the data gathered
over three separate days.
3.2.7. Recovery, matrix effect and stability
The recovery of ATOEA was determined by the analysis of five QC replicates (low,
medium and high concentrations) prepared in aqueous solution compared with equivalent
QCs in plasma. Recovery (i.e., signal recovery) was determined as a percentage by dividing
the analyte signal peak area from spiked plasma by the peak area of the equivalent aqueous
QC standard. Calibration curve equations for calibrators prepared in DI water and plasma
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were compared to evaluate matrix effects. A slope ratio (plasma slope/aqueous slope) from
the calibration curves <1 indicates suppression effect, whereas slope ratio >1 indicates an
enhancement effect.
The stability of ATOEA in plasma was evaluated by analyzing low and high QCs
stored at various temperatures at multiple storage times. The stability (i.e., signal stability)
of ATOEA was calculated as a percentage of the initial signal, with ATOEA considered
stable at a particular temperature if the signal was within 15% of the initial signal. Shortterm stability was assessed in the autosampler for 24-hrs, on the bench top (at room
temperature) for 24 hr, and over multiple (3) freeze-thaw cycles. Long-term stability
experiments were conducted under various storage conditions (-80, -20, and 4 ⁰C) for 0, 2,
4, 6 10, 20, and 30 days.
3.2.8. Toxicokinetic Analysis
The toxicokinetic behavior of ATOEA after intravenous administration of CN at
different time points was modeled with a two-compartment model.[162] The maximum
concentration (Cmax) of ATOEA in plasma, time taken to reach maximum concentration
(Tmax), distribution constants (Kdis), elimination constants (Kel), distribution half-life
(t1/2,dis) and elimination half-life (t1/2,el) were obtained from the concentration-time curve.
Area under curve (AUC) after apnea was also obtained from the concentration-time curve
using trapezoidal rule. The correlation between the concentrations of ATOEA and
ATOEA-13C15N after intravenous administration of CN and 13C15N (1:1) was determined
by student t-test
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3.3. Results and Discussion
3.3.1. Mechanism of glutathione-cyanide interaction
Previous studies on the cyanylation of sulfhydryl groups of peptides and proteins
have demonstrated that CN reacts with thiol of the cysteine residue in a peptide/protein to
form a covalently bonded peptide/protein-CN adduct at pH values slightly above
neutral.[116, 159, 160] In 1974, Dagani[160] demonstrated that at pH 8-10, the adduct
cyclizes at the N-terminus of the cysteine residue, which then cleaves to form a 2iminothiazolidine derivative. In this study we modelled the interaction of CN with
sulfhydryl groups of peptides/proteins[116, 159, 160] using glutathione (GSH) as the
peptide. Figure 3.1 shows the proposed reaction scheme for the reaction of GSH with
NH2CN. In summary, the thiol group of GSH is proposed to react with the CN of NH2CN to form a glutathione-CN adduct (GS-CN),[116, 159] releasing ammonia gas (NH3) in
the process.[60] This reaction is supported by a number of studies.[60, 116, 159, 160] As
the reaction proceeds, more NH3 gas is released into the reaction contents, increasing their
basicity (pH=11).[60] Subsequently, the NH3 gas escapes the reaction contents and the pH
of the contents decrease.[60] Once the pH of the reaction contents decreases to between 810, the GS-CN adduct likely undergoes intramolecular cyclization between the N-terminus
of the cysteine residue and the C≡N bond,[160] which cleaves the glutamate-cysteine
peptide bond to produce 2-iminothiazolidine (i.e., ITOEA, which tautomerizes to 2aminothiazoline derivative (ATOEA))[60, 116, 160] similar to ATCA.[159] The
cyclization also produces glutamic acid,[159] which cyclizes to produce pyroglutamic acid
(PGA) as a byproduct.[161]
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3.3.2. ATOEA and PGA as biomarkers
To confirm the formation of ATOEA from CN exposure, analytical methods were
developed to quantify pyroglutamic acid and ATOEA in plasma of cyanide-exposed rabbit.
The mass spectra of ATOEA and ATOEA-13C15N are shown in Figure 3.2. Figure 3.2a
shows the mass spectrum of ATOEA produced by ESI(+)-MS with the molecular ion
structure ((M+H)+, m/z = 204) inset. The mass spectrum of ATOEA-13C15N ((M+H)+, m/z
= 206) with its abundant ions identified as produced by ESI(+)-MS is shown Figure 3.2b.
For ATOEA, transitions 204→101 and 204→158 were used for quantification and
identification, respectively. The quantification and identification transitions for ATOEA13 15

C N were 206→103 and 206→160, respectively. The optimized MS-MS parameters for

the detection of both ATOEA, ATOEA-13C15N and PGA are shown in Table 3.1.
Figure 3.0 shows the HPLC-MS-MS chromatograms of ATOEA (Fig 3.3a) and
PGA (Fig 3.3b) analyzed from spiked rabbit plasma, and plasma from pre- and postcyanide exposed rabbits. The representative HPLC-MS-MS chromatograms of the MRM
transitions of ATOEA analyzed from spiked water are also depicted in Figure 3.3c. The
ATOEA eluted at approximately 3.1 min with only small endogenous ATOEA signal
visible in the pre-exposed samples. PGA eluted at approximately 2.4 min with large
endogenous concentrations of PGA in pre-CN exposed samples. Therefore, although we
were able to consistently verify increasing concentrations of PGA following CN exposure,
the relatively large endogenous concentration of PGA in non-exposed animals limits the
usefulness of PGA as cyanide biomarker. Therefore, ATOEA was the focus of the rest of
the study. Although ATOEA was the focus of the study, the increase in both ATOEA and
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PGA in the plasma of CN-exposed animals supports the reaction scheme shown in Figure
3.1 as the biological process responsible for the production of ATOEA.
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Figure 3.3. ESI(+) mass spectra of ATOEA (A), and ATOEA-13C15N (B) with
identification of the abundant ions. Insets: Structures of ATOEA (A), and ATOEA-13C15N
(B) with abundant fragments indicated.

49

Intensity (Arbitrary unit)

Peak Area (×106)

5

A

4
3
2
1
0
Pre-CN
eposure

Post-CN
exposure

ATOEA spiked Plasma

Post-CN exposure

Pre-CN exposure

0

1

2

3

Time (min)

4

5

50

15
Peak Area (×106)

B
Intensity (Arbitrary unit)

10
5
0
Pre-CN Post-CN
eposure exposure

PGA Spiked Plasma

Post-CN exposure

Pre-CN exposure

0

1

2

3

Time (min)

4

5

51

C
Intensity (Arbitrary unit)

204 → 101

204 → 59

204 → 74
204 → 158

0

1

2

3

4

Time (min)
Figure 3.4. HPLC-MS-MS chromatograms of ATOEA (A), PGA (B) and ATOEA MRM
transitions (C). A: ATOEA-spiked rabbit plasma and the plasma of a cyanide-exposed
rabbit, pre-exposure, and post-exposure. B: PGA-spiked rabbit plasma and the plasma of a
cyanide-exposed rabbit, pre-exposure, and post-exposure. C: Signal response to the MRM
transition of ATOEA (10 µM) spiked aqueous standards (204→101, 204→59.0,
204→74.1, and 204→158.0). The chromatograms represent the signal response of the
MRM transition 204.0→101, and 130.0→84 m/z for ATOEA (A) and PGA (A),
respectively. Inserts: Peak areas of pre-CN exposure and post-CN exposure (25 min
infusion) plasma sample for ATOEA (A) and PGA (B).
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3.3.3. HPLC-MS-MS Analysis of ATOEA
The analytical method for ATOEA involved quick and simple sample preparation,
consisting of protein precipitation, centrifugation, transfer of supernatant, drying, and
reconstitution in aqueous ammonium formate, for HPLC-MS-MS analysis. Even with this
simple sample preparation protocol an internal standard was not necessary to correct for
matrix effects or incomplete recovery. The sample preparation time was approximately 20
min and the HPLC-MS-MS analysis time was 10 min. Despite the quick and simple sample
preparation and analysis, the ATOEA was completely resolved from other components in
the matrix and showed a sharp peak eluting at approximately 3.1 min, but considerable
tailing (As= 2.31).
ATOEA calibration curves were constructed in rabbit plasma within the
concentration range of 0.2-300 μM. The 0.2, 100, 200 and 300 μM calibrators fell outside
the entire linear range based on the accuracy and precision criteria, producing a linear range
of 0.5 to 50 μM, which was best described by a 1/x2 weighted linear regression. The percent
residual accuracy (PRA) values of all the calibration curves analyzed were ≥ 95%,
indicating excellent fit of the data over the entire linear range (i.e., PRA values ≥ 90% are
indicative of a good fit).[128]
The accuracy and precision of the method were determined by quintuplicate
analysis of three different QC standards (0.75, 4, and 30 μM) on three different days (Table
3.2). The precision of the method was excellent, with both the intraassay and interassay
analysis producing percent relative standard deviation (%RSD) values of <6%. The
accuracy for intraassay and interassay analyses was also excellent (100±8% of nominal
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QC concentration). The LOD was 0.2 μM ATOEA in plasma as validated by analysis of
multiple ATOEA-spiked samples over a 3-day period.

Table 3.2. The accuracy and precision of ATOEA analysis from spiked rabbit plasma by
HPLC-MS-MS.
Intraassay
Conc (μM) Accuracy

Interassay
Precision (%RSD)a

Accuracy (%)b

Precision (%RSD)b

(%)a

a

0.75

100±2.4

4.19

100±7.8

5.63

4

100±7.6

3.75

100±5.0

3.71

30

100±7.4

4.08

100±6.9

3.49

QC method validation (N = 5) for day 3

b

Mean of three different days of QC method validation (N = 15)

The matrix effect was assessed by comparing the slopes of standard curves of
ATOEA in aqueous calibrators (deionized (DI) water) and plasma. The slope of the
aqueous curve was approximately 2 times the slope of plasma calibration curve. Therefore,
a significant matrix effect exists for the analysis of ATOEA from plasma via the current
method. Recovery for low, medium, and high QCs were 59%, 45%, and 55% respectively.
Because the % recovery value is the combination of matrix effect and recovery, the
recovery values can be attributed to the matrix effect suppression of the ATOEA signal
instead of low recovery.
The long-term stability of ATOEA was evaluated for 30 days at -80, -20, and 4 ⁰C.
ATOEA was stable at -80 ⁰C for 30 days, at -20 ⁰C for 4 days, but degraded rapidly at 4

54
⁰C (i.e., stable for only 2 days). For short-term stability, prepared samples of ATOEA were
stable for at least 20 h on the autosampler but were only stable for 6 h on the bench-top,
showing that ATOEA degraded relatively quickly in plasma at room temperature.
Additionally, ATOEA was stable in plasma for 3 freeze-thaw cycles. From the results of
the stability studies, we recommend that when storage is necessary, that plasma samples
are stored at -80 ⁰C and can be thawed and refrozen 3 times for analysis. If samples are to
be analyzed within 4 days, they can be stored at -20 ⁰C.
3.3.4. Toxicokinetics of ATOEA in rabbits following cyanide exposure
To definitively confirm the direct relationship between cyanide exposure and the
production of ATOEA, rabbits were exposed to a 1:1 mixture of labeled (13C15N-) and
unlabeled (CN-) cyanide. The concentrations of ATOEA and ATOEA-13C15N in plasma of
cyanide-exposed rabbits mirror each other, as shown in Figure 3.4. ATOEA was below the
LOD in pre-exposed rabbit plasma. The concentration of both ATOEA and ATOEA-13C15N
increased rapidly during the infusion of CN- and 13C15N-, and then decreased quickly after
apnea (at Cmax) following stopping CN administration and the administration of antidote.
The decrease of ATOEA concentration when the cyanide infusion was stopped (after
apnea), and after glyoxylate was administered may be due the ability of carbonyl group of
glyoxylate to bind with free cyanide to form cyanohydrin or the rapid distribution and
elimination of CN.[163] There was excellent agreement (R2 = 0.9924, p < 0.05) between
the concentrations of ATOEA and ATOEA-13C15N from plasma of cyanide exposed
rabbits.
The identification of ATOEA-13C15N in rabbit plasma after

13 15

C N was the

administered, confirms that ATOEA is produced during the metabolism of CN. The
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percentage of cyanide converted to ATOEA was estimated at about 1.25-4.10%. This
estimation was based on the measured ATOEA and cyanide concentration after factoring
in the estimated percentage of cyanide that detoxified to ATCA and thiocyanate as reported
by Bhandari et al,[89] and the percent distribution of cyanide between plasma and RBCs
(i.e., 70-96% of the blood cyanide is found in RBCs).[106]

Table 3.3. Toxicokinetic parameters of ATOEA in rabbits following intravenous infusion
of CN. These parameters are likely a combination of ATOEA elimination and sequestration
of CN by glyoxylate.
Cmax (µM)

t1/2dis (min)

t1/2el (min)

Kdis

Kel

AUC (µM*min)

3.79

14.87

92.20

0.0466

0.0075

55.60

Table 3.3 shows the toxicokinetic parameters for ATOEA. The formation of
ATOEA in rabbits was rapid and it mirrored the cyanide dose. Once the cyanide infusion
was stopped, the ATOEA was distributed and eliminated. A two-compartment model best
described the toxicokinetic behavior of ATOEA, with a calculated elimination half-life
(t1/2,el) of 92.2 min (Kel = 7.5 ×10-3 min-1).

56

Concentration (μM)

4

3

2

log (Conc)

5

0
-0.1
-0.2
-0.3
-0.4
-0.5
-0.6
-0.7
-0.8

y = -0.0075x - 0.0472

Kel = -0.0075 min-1
0

50

100

Time (min)
ATOEA
ATOEA

1

ATOEA13C15N
13C15N
ATOEA

0
-30 -20 -10 0 10 20 30 40 50 60 70 80 90 100

Time (min)
Figure 3.5. Plasma concentrations of ATOEA and ATOEA-13C15N following exposure of
rabbits to equal amounts of CN- and 13C15N. Pre-exposure, 15 min, 25 min, and 35 min,
following cyanide exposure are designated as time -25, -20, -15, and -10 respectively.
Apnea is represented by time zero. Error bars represent standard error of the mean (SEM).
Inset: Representation of elimination constant (Kel) of ATOEA by log concentration-time
graph.

3.3.5. ATOEA as a biomarker of cyanide exposure
ATOEA may be a better long-term biomarker for cyanide exposure than cyanide
itself because of its slower elimination half-life (t1/2,el), and large area under the curve (55.6
µM*min). The low concentrations of ATOEA in pre-exposure plasma samples, and the
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early detection of ATOEA, within a few minutes of CN exposure, suggest that ATOEA can
also be used as a diagnostic biomarker for both acute and high-dose CN poisoning.
Although ATOEA has many advantages as a marker of cyanide poisoning, its limitation is
its poor stability in plasma at temperatures above -80 ⁰C. Future work should identify the
degradation product of ATOEA in biological samples and the stability of this product.
3.4. Conclusions
A novel cyanide metabolite, ATOEA was found based on the interaction of
glutathione and cyanide. A rapid and simple HPLC-MS-MS with excellent accuracy and
precision was successfully developed to quantify ATOEA in plasma and applied to analyze
plasma of rabbits exposed to cyanide. The toxicokinetics of ATOEA from rabbits exposed
to cyanide confirms that it is a promising biomarker that can serve as both a diagnostic and
potentially forensic biomarker for cyanide exposure.
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Chapter 4. Verification of Cyanide-Poisoned Fish By Field Portable Detection of The
Cyanide Metabolite, Thiocyanate From Fish Blood
4.1. Introduction
Since the 1930s, live reef fish have been legally harvested for the marine aquarium
trade (MAT) and live reef fish for food trade (LRFFT) industries.[69] The demand for live
reef fish in these industries increased in the middle of the 20th century, resulting in the
integration of illegal methods, such as cyanide fishing, to meet this demand.[164] The use
of cyanide fishing first originated in the Philippines in the early 1960s,[69, 70] and the
practice has spread throughout many regions including China, Indonesia, Malaysia, the
Maldives, Papua New Guinea, Sri Lanka, Thailand and Vietnam.[71-74] Cyanide fishing
involves the use of cyanide (abbreviated as CN, representing both hydrogen cyanide and
cyanide ion) to stun and disorient valuable fish hiding in coral reefs, making them easier
to collect. Cyanide fishing is accomplished via two main techniques: 1) the manual
spraying of a saturated solution of CN salt from a squirt bottle at a fish hiding in a coral
reef, and 2) pumping large volumes (about 200 L) of saturated CN solution from a fishing
boat into a coral reef area and collecting stunned fish by hand netting.[76, 165, 166]
Because CN fishing is much more immediately profitable compared to legal fishing
methods (2.5-10 times),[67, 68, 167] it has become so popular that an estimated 150-640
metric tons of CN are used for CN-fishing annually.[75] Although it is more profitable in
the near term, it is a major threat to the health of coral reefs, marine life which depend on
these reefs, the coastal and ocean environments, and the future fishing industry in the West
Pacific Ocean.[168]
CN has many deleterious effects on the marine ecosystem and the fish trade. Firstly,
CN can damage targeted fish, which can ultimately result in death.[72] Studies have shown
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that 5-75% of the targeted fish collected by CN for aquarium trade die a few hours postharvest, with more than 90% mortality rate recorded from collection to consumer.[72, 80]
Additionally, many targeted species, such Cheilinus undulates, are on the verge of
extinction as result of the effectiveness of CN fishing.[78, 79] CN fishing also affects nontargeted species.[81] One of the most concerning effects of CN-fishing is its impact on
coral reefs. CN interrupts coral-algal symbiosis, a process that provides nutrients to the
coral, resulting in a process called “bleaching,” where colored coral becomes white and
pale.[82, 169, 170]
The damage to marine ecosystems produced by CN fishing has led to about 80%
of fish exporting countries banning the practice.[74, 171] Although CN fishing is banned
in most exporting countries, the technique is still commonly practiced[67, 68] because
enforcement of anti-CN fishing laws is difficult, partially due to the lack of a reliable test
to determine if fish were CN caught.[172] The availability of a reliable testing technology
to detect CN exposure post-harvest would not only help in the enforcement of the anticyanide fishing laws by government authorities, but may also allow testing by wholesalers
and retailers.[172, 173]
While the direct analysis of CN from biological fluids can be used to confirm CN
exposure immediately following an exposure event, it is increasingly unreliable as the time
post-exposure increases.[111] This is because CN is reactive and volatile, leading to a very
short half-life in most animals (e.g., 0.34–1.00 hr in humans; see Table 1) and instability
in biological matrices.[55, 60, 137] Therefore, indirect analysis of stable markers of CN
has been proposed as a means to confirm CN exposure, especially at times greater than a
few hours post-exposure. Thiocyanate (SCN-; represented as SCN herein) is the major
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metabolite of CN, accounting for about 80% of the total CN metabolism.[55, 89, 137] SCN
is a longer-lived marker of CN exposure (Table 1), with half-lives ranging from 4.95-192
hr in mammals and 2.4-144 hr in fish.[55, 107, 113, 174] The main drawback of using SCN
as a marker for CN exposure in most animals is that SCN is consumed or produced via
diet. This leads to large and highly variable background concentrations of SCN in
mammalian blood (474-32900 µg/L) resulting from sources other than CN exposure (Table
1). Therefore, the use of SCN to confirm CN exposure in mammals is highly
questionable.[55, 136] Similarly, while data is limited and inconsistent, previous studies
have suggested that some freshwater fish have high levels of SCN in their blood (not
detected-5100 µg/L) from sources other than CN exposure.[175-178] Conversely, marine
fish have much lower endogenous SCN concentrations (<50 µg/L) than mammals, likely
because they have diets low in SCN-containing and SCN-producing foods.[174, 179]
Therefore, acute CN exposure should lead to highly elevated SCN concentrations in fish.
Additionally, since SCN has a long half-life relative to CN in both fish and mammals,
elevated levels of SCN should persist for relatively long periods of time following CN
exposure.[178, 180, 181] Breen et al. (2019) demonstrated both greatly elevated SCN
levels following CN exposure and long-lived elevation of SCN concentrations (i.e., 41 days
post-exposure) in CN-exposed fish.[179] A recent study also reported high elevation of
SCN concentration in blood plasma of marine fish following CN.[174] Therefore, the
properties of SCN in fish appear to be ideal for the use of SCN as a promising marker for
determination of CN-caught fish.[178]
In recent years, researchers have proposed two potential matrices for the analysis
of SCN to determine CN-caught fish: holding seawater or blood.[178-180, 182, 183]
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Holding seawater is fresh seawater to which CN-caught fish are transferred in order to
revive the fish and hold them for transport. It is suggested that SCN is excreted in the urine
of CN-caught fish into the holding seawater. In fact, analysis of excreted SCN in seawater
to confirm CN-fishing has been previously reported,[180, 181, 184] but several attempts
to replicate these findings by other scientist have failed.[185, 186] Bonanno et al. (2020)
reported that marine fish (A. clarkii) do not excrete SCN after CN exposure and can absorb
low concentrations of SCN from water refuting these studies.[174] Although this approach
has advantages of being non-invasive, non-destructive, and easy,[180] this approach has
not be reproducibly verified. Moreover, fishers could easily replace or adulterate the
holding seawater (e.g., by using masking agents) to avoid being caught by authorities. The
analysis of SCN from fish blood is very difficult to adulterate and long-term elevation of
SCN in fish blood following CN exposure has been shown.[179] While both the analysis
of holding seawater and blood have advantages, blood SCN is the most definitive way to
monitor CN-fishing.
Scientists have developed and suggested multiple analytical SCN testing methods
to monitor CN fishing.[71, 180, 181] In the late 1990s, Barber and Pratt developed an ion
selective electrode technique to monitor CN-fishing, but the method produced low
sensitivity, accuracy, and recovery.[71, 182, 187] More recently, Vaz et al. (2012 and
2017) reported two analytical techniques (i.e., HPLC-optic fiber and HPLC-UV) to
analyzed SCN from sea water, with the purpose of detecting SCN excreted from CN-caught
fish into the sea water used to hold fish.[180, 181] Though the Vas et al. methods feature
rapid sample preparation and are non-invasive, they require sophisticated instrumentation,
are not portable, and the results were not reproducible.[185, 186] Breen et al.[185] also
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used the Bhandari et al.[137] LC-MS/MS method for analysis of SCN from seawater to
verify concentration found from the HPLC-UV technique. This method provided featured
quick and easy sample preparation, very good accuracy, linearity, and sensitivity, but it
required expensive and sophisticated instrumentation and was not rapid or field portable.
Breen et al.[179] reported an HPLC-UV method to analyze SCN in fish plasma for
toxicokinetic studies of SCN in CN-exposed fish. The method was featured excellent
sensitivity and simple sample preparation, but required sophisticated instrumentation,
somewhat difficult preparation of chromatographic media, utilized plasma as opposed to
whole blood (i.e., creating the additional requirement of blood component separation,
adding time and complexity to the analysis), and was not field-portable. While these
methods proved useful for research studies, each has its drawbacks for monitoring CNfishing, including the fact that none of the methods are truly rapid (i.e., as defined as sample
preparation and analysis times of less than about 5 min), field-portable or simple, which
may be essential for monitoring CN-fishing.[179-181, 184]
Recently, our lab developed and validated an automated field-portable
fluorescence-based sensor for the analysis of CN in blood to confirm exposure.[7, 54, 188]
The technology features a short analysis time (60 s), a small sample volume (25 µL), field
portability (approximate dimensions of 24.2 × 16.7 × 10.8 cm (L × W × H) and a mass
<0.1 kg), and user-friendly operation that does not require special expertise. The sensor
was successfully used to analyze CN from the blood of CN-exposed mammals (i.e., rabbits
(N = 205)). While the sensor was excellent for measuring CN, it was not designed to
analyze SCN.
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Considering the effect of CN-fishing on marine ecosystems and economies, there
is a critical need to develop a reliable, field-portable, and easy to operate technology to
confirm CN exposure in fish caught from countries where CN-fishing is practiced.
Therefore, the objectives of this study were to extend the CN sensor technology developed
in our lab for the analysis of blood SCN, to validate the analytical characteristics of the
sensor, and to confirm its ability to accurately quantify elevated SCN levels from the blood
of marine fish exposed to CN.
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Table 4.1. Endogenous blood concentrations and half-lives of cyanide and thiocyanate
from acute exposures of cyanide for multiple animal models. Adapted and updated from
Logue et al.[55]
Marker of CN
Animal

Endogenous Concentration
Species

Half-life (hr)

Exposure

CN

Range (µg/L)
Human

0.34-1.0[55, 189]

0.52-2.10[110, 191]

Pig

0.54[190]

229.3[89, 192]

Rat

0.64[190]

5.0-280[193]

Goat

1.28[190]

ND

Rabbit

2.95[89]

99.8-145.9[89, 192]

Human

96-192[189]

1792-32944[55, 117, 194]

Pig

4.95[190]

473.9-2384[89, 190, 195]

Rat

5.8-50[89, 190]

1160-3074[190, 196]

Goat

13.9[190]

ND

Rabbit

ND

501[192]

Rainbow Trouta

48.5[178]

ND-5100[175-177]e

Salmonb

ND

58

Clownfishc

144[178, 179]

<50[179]f

Clownfishd

2.4-28.8[174]

34[174]

Mammals

SCN

Fish

SCN

ND = Not determined. aOncorhynchus mykiss. bSalmo salar, Current study. cClownfish (A.
ocellaris). dClownfish (A. clarkii). eMultiple Rainbow Trout studies were conducted with SCN not
detected in two groups with N= 6 and 10, respectively, and mean concentrations of 360, 820, and
5100 ppb for groups of N= 9, 6, and 6, respectively. fEndogenous concentration was below the
LOQ (50ppb) of the method.
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4.2. Materials and Methods
4.2.1. Materials
All reagents and solvents were at least HPLC grade. Sodium cyanide (NaCN),
sodium hydroxide (NaOH), sulfuric acid (H2SO4), ethanol, methanol, potassium
dihydrogen phosphate (KH2PO4), and dibasic potassium phosphate (K2HPO4) were
purchased from Fisher Scientific (Hanover Park, IL). Taurine (2-aminoethane sulfonic
acid) and sodium metaboratetetrahydrate (NaBO2·4H2O) were purchased from Alfa Aesar
(Ward Hill, MA). Sodium thiocyanate (NaSCN) was obtained from Acros Organics
(Morris Plains, NJ). Potassium permanganate (KMnO4) was purchased from Science
Company (Lakewood, CO) NDA (2,3-Naphthalene dialdehyde) was obtained from TCI
America (Portland, OR). Tricaine methanesulfonate was obtained from Western Chemical
Inc. (Ferndale, WA). Water was purified to 18.2 MΩ-cm by reverse osmosis using a Lab
Pro polishing unit from Labconco (Kansas City, KS, USA).
A stock solution of NaOH (1 M) and phosphate/borate buffer (0.1 M:0.05 M; pH
8.5) were prepared in DI water. Stock solutions of NaCN (2 mM) and NaSCN (1 mM)
were prepared in 10 mM NaOH. H2SO4 (2 M) was prepared as 50:50 v/v aqueous and
ethanol. Taurine (0.1 M) solution was prepared in phosphate borate buffer. A stock solution
of NDA (2 mM) was prepared in phosphate borate buffer and 40% methanol. A saturated
solution of KMnO4 was prepared in DI and its concentration (0.6 M) was determined by
titrating it against 0.2 M oxalic acid.
Caution: CN is highly toxic to humans and animals. Therefore, CN solids and
solutions must be handled with care. All CN solutions were handled in a hood and prepared
as basic aqueous solutions (10 mM NaOH) to ensure CN remained as non-volatile CN-.
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4.2.2. Fish Blood for SCN Analysis
Salmon whole blood (EDTA anti-coagulant) used for analytical method
development was purchased from EastCoast Bio (North Berwick, ME) and stored at -80 °C
until used. Salmon whole blood was used instead of blood from a marine fish because we
were unable to identify a source of large quantities of marine fish whole blood.
Fish blood from CN-exposed and control marine fish was obtained from
Department of Chemistry and Physics, Roger Williams University, Bristol, RI, USA.
Marine fish (5.1-21 g), A. clarkii, approximately 6-12 months of age, were split into three
groups, each group having 10-12 fish. Each group was placed in a basket and immersed in
a CN solution (at 50 ppm) or control for 45 s. After exposure, the fish were transferred into
a seawater bath free of CN for rinsing. After rinsing, fish were housed in 20 L
polycarbonate tanks containing CN-free filtered seawater with light aeration. After 72 hr,
fish were removed from the holding tanks for blood collection. Firstly, fish were
anesthetized with tricaine methanesulfonate at a concentration of 200 ppm, buffered 2:1
with sodium bicarbonate in seawater, and then dried and weighed. Upon severance of the
caudal peduncle with a #21 surgical blade, blood was collected in 125 µL heparinized
microcapillary blood collection tubes. Blood was similarly collected from a control group,
which was not exposed to CN. Collected blood was placed in clean plastic centrifuge tubes,
flash frozen, and shipped on dry ice (overnight) to South Dakota State University. Upon
receipt, the blood was stored at -80 °C until analysis was performed.
The Roger Williams University Institute of Animal Use and Care Committee
(Approval #R180820) approved all fish experiments. Fish were cultured in captivity at
Roger Williams University or Sea & Reef Aquaculture, Franklin, ME, thereby ensuring

67
they were not collected with cyanide. For all experiments, the water temperature was
maintained by housing fish in a temperature-controlled room or placing buckets containing
fish in a warm water bath both held at 25 oC. All fish were fed pelletized food (Skretting
Green Granule 1 mm) once per day unless otherwise noted. Water quality was maintained
through daily water changes (100%) at a salinity of 30 with light aeration.
4.2.3. Sensor Analysis of SCN
The analysis of fish blood was performed using a previously developed sensor
prototype (Figure 4.1) which consists of a self-contained sample preparation cartridge
(Figures 4.1A and B) and a detection system (Figures 4.1C and D). The CN sensor
chemistry was modified for the analysis of SCN by adding KMnO4 to oxidize SCN to CN,
with the resulting CN analyzed as described in Bortey-Sam et al.[188] Briefly, a saturated
aqueous solution of KMnO4 (80 µL of a 94 mg/mL solution) was added to the sample
chamber of the cartridge (Figure 4.1A & 4.1B) and the water was completely dried. Fish
whole blood (25 µL of non-spiked, SCN-spiked, or CN-spiked salmon blood or blood from
CN-exposed or non-CN-exposed marine fish) was carefully added to the sample chamber,
avoiding contact with the dried KMnO4, water (80 µL) was then added to dissolve the
KMnO4. The cartridge was capped, placed into the fluorometric reader, and the analysis
was started. H2SO4 (2 M, 200 µL) was automatically added to the sample chamber and 200
µL each of NDA, taurine, and base solutions were automatically added to the capture
chamber. In the sample chamber, the KMnO4 was dissolved via addition of the H2SO4
solution and SCN was oxidized into CN by KMnO4. The CN was then liberated from the
blood matrix in the sample chamber by acidification with H2SO4 to form HCN gas.
Ambient air (approximately 200 mL/min for 34 s) was used as carrier gas to transfer the
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HCN from the sample chamber into the capture chamber (Figure 4.1A), where it was
captured by the NaOH solution, forming CN-. Taurine and NDA reacted with the captured
CN- in a linear fashion to form a fluorescent β-isoindole product. Throughout this process,
the capture solution was mixed by bubbling air via a specific protocol, aiding the βisoindole formation. A high-powered LED was directed into the capture solution through
a focusing lens to illuminate the mixture and the fluorescence of the β-isoindole product
was measured at 400-650 nm (Figure 4.1D) to quantify the SCN concentration. Most of
the steps described above are automated (i.e., initiated by the user by pushing a single
button).
4.2.4. KMnO4 Oxidation of SCN to CN
The ability of KMnO4 to completely oxidize SCN to CN was evaluated by
analyzing CN-spiked blood without KMnO4 (5 µM, as a positive control), and the same
concentration of SCN-spiked blood with KMnO4 (as a sample) and without KMnO4 (as a
negative control). Non-spiked blood samples with KMnO4 and without KMnO4 oxidation
were also analyzed as a sample blank and negative control blank, respectively. The blank
subtracted average signals of the positive and negative control samples were compared to
the blank subtracted average signal of SCN-spiked blood to evaluate the ability of KMnO4
to oxidize the SCN to CN.
4.2.5. Analysis of Total CN
To evaluate if the sensor was measuring total CN (CN + SCN) in the blood matrix
or SCN only, the same concentrations (1-10 µM, 58-580 µg/L) of CN and SCN were
prepared separately in salmon blood. The sensor was used to analyze the concentrations of
both CN and SCN in these samples. In addition, standards of both CN and SCN were
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spiked in the same fish blood to create mixed standards of 1-10 µM (58-580 µg/L) each for
CN and SCN (i.e., CN + SCN concentrations of 2-20 µM, 116-1160 µg/L). Blank signals
were evaluated using non-spiked and KMnO4 oxidized salmon blood. The blank-corrected
sum of signals of the individually spiked CN and SCN samples was compared to the signal
of the sample containing both CN and SCN.
4.2.6. Background Concentration of SCN in Salmon Blood
The background concentration of SCN in salmon blood was determined using
standard addition. Briefly, different concentrations of SCN working standard were spiked
into the same volume of salmon blood to produce final spiked concentrations of 0, 0.5, 1,
3, and 5 µM (0, 29, 58, 174, and 290 µg/L). These samples were analyzed in triplicate using
the sensor and the mean signals were plotted as a function of the nominal spiked
concentration to obtain a linear curve with a non-zero Y-intercept. The curve was
extrapolated to the concentration axis (x-axis) to find the background concentration of SCN
in salmon blood. This experiment was repeated 3 times and the mean background SCN
concentration, along with its confidence level, was calculated. The confidence level was
calculated at the 95% confidence interval. Enough marine fish blood could not be collected
to perform the standard addition method.
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FIGURE 1A

FIGURE 1B
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FIGURE 1C
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FIGURE 1D
Figure 4.1. Schematics of the sample preparation cartridge and fluorescence detection
system for the analysis of SCN in fish blood adopted from Bortey-Sam et. al.[188] A) The
sample preparation cartridge “front” view highlighting carrier gas channels, the sample
chamber and the capture chamber. B) The sample preparation cartridge “back” view
highlighting the reagent storage “bubbles,” the reagent flow channels, the sample chamber
and the capture chamber. C) The fluorescence detection system highlighting the sample
preparation cartridge holder, the carrier gas pump, the linear actuator for depression of the
reagent bubbles, the touch screen, and the microprocessor. D) The sample preparation
cartridge showing the position of the optical components for fluorometric analysis of the
CN-NDA-taurine complex.
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4.2.7. Analytical Method Development and Validation
The analytical method for the analysis of SCN in salmon blood via the sensor was
validated following the FDA bioanalytical method validation guidelines.[126] From the
SCN stock solution, a working standard of SCN was prepared from dilution with salmon
blood. From the working standard, calibration standards of SCN, blank, 0.3, 0.5, 1, 3, 5, 8,
10, and 20 μM (blank, 17.4, 29, 58, 174, 290, 464, 580, and 1160 µg/L) were prepared via
dilution with fish blood and analyzed in triplicate by the sensor. Following analysis, the
average signals measured by the sensor were plotted as a function of the concentration of
SCN spiked in blood to obtain the linearity, accuracy, and precision of the calibration
standards. Calibration curves were created using non-weighted linear least squares to
obtain the equation of the line. The lower limit of quantification (LLOQ) and upper limit
of quantification (ULOQ) were defined as satisfying the inclusion criteria of a precision of
≤20% relative standard deviation (RSD), and accuracy of a percent deviation within ±20%
of the nominal concentration for all calibration standards within the linear range. The
goodness-of-fit of the calibration curves was determined using both Percent Residual
Accuracy (PRA)[128] and the coefficient of determination (R2). The limit of detection
(LOD) was defined as the lowest concentration of SCN that produced a signal equal to the
summation of the mean blank signal and 3 times the standard deviation of the blank.
The accuracy and precision of the method were determined by analyzing three QC
standard concentrations of SCN prepared in fish blood with concentrations of 2 μM (116
µg/L, low QC), 4 μM (232 µg/L, medium QC), and 7 μM (406 µg/L, high QC). All the
QCs were within the calibration range but not included in the calibration curve and
analyzed in quintuplicate each day for 3 days. Intraassay precision and accuracy were
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evaluated from each day’s analysis, and interassay precision and accuracy were calculated
from comparison of the data gathered over three separate days.
4.3. Results and Discussion
4.3.1. Sensor Analysis of SCN and CN
A CN sensor previously developed in our lab proved to be excellent for the rapid,
simple and field-portable analysis of CN from blood.[188] Considering the excellent
performance of the sensor for CN, we hypothesized that incorporation of KMnO4 to oxidize
SCN to CN would allow conversion of the CN sensor to an SCN sensor. While the practical
implementation of KMnO4 into the sensor was challenging, the overall hypothesis was
confirmed, with KMnO4 converting SCN to CN and subsequent analysis of CN via the
previous CN analysis method. Because the CN sensor was modified to allow SCN analysis,
the SCN sensor features all the advantages of the CN sensor. Most importantly for
monitoring CN fishing, the overall sample preparation and analysis time is only 60 s, it
requires a very small volume of blood (i.e., allowing monitoring of CN fishing without
requiring the sacrifice of the fish tested and allowing testing of even very small fish), it is
portable, and it is easy to use. Additionally, the reagents are stable, with the dry KMnO4
evaluated as stable in the cartridge for at least 30 days (longest period tested). In addition,
the simplicity of the analysis should allow all stakeholders to monitor CN-fishing, i.e.,
operation does not require special expertise and all sample preparation steps are automated.
It should be noted that obtaining blood from live fish would require special expertise, but
once the blood is obtained, analysis of SCN via the sensor is rapid and simple.
The fundamental difference in the SCN and CN sensors was the use of KMnO4 to
initially oxidize SCN to CN, with analysis of the CN produced as previously
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described.[188] Therefore, the analysis of SCN via the current sensor relied on consistent
conversion of SCN to CN via oxidation by KMnO4. Consistent oxidation of SCN was
evaluated by repeated comparison of the blank-corrected signals produced from fish blood
spiked with the same concentrations (5 µM/290 µg/L) of CN (no KMnO4 oxidation), SCN
(no KMnO4 oxidation), and SCN with KMnO4 oxidation over three days (N = 3). Signals
produced from non-spiked, fish blood (no KMnO4 oxidation) were comparable to signals
produced from SCN-spiked fish blood (no KMnO4 oxidation). Equivalent signals from
these two samples confirmed that oxidation is necessary for the analysis of SCN via the
sensor. The signal produced from SCN-spiked KMnO4-oxidized fish blood was
significantly above the non-oxidized blood samples, but equivalent to the signals from CNspiked fish blood. This indicates that the oxidation of SCN to CN was efficient, likely
converting essentially all the spiked SCN to CN, and that KMnO4 did not create significant
matrix effects for the analysis of SCN, although it did produce slightly larger background
signals.
Directly following CN exposure, the majority of CN in an organism has yet to be
converted to SCN. Therefore, the detection of both CN and SCN from biological fluids
using the same technology would be advantageous, allowing the determination of CNcaught fish in both the early stages of exposure and long after the exposure occurred. The
current sensor technology was evaluated for the potential of analyzing both CN and SCN
as “total CN”. To evaluate the ability of the sensor to measure total CN, the sum of signals
of the separately spiked CN and SCN blood was compared to the signal of the blood sample
containing both CN and SCN, as shown in Figure 4.2. Overall, the sum of the signals
produced from the individually spiked fish blood are not significantly different from the
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signal produced by CN and SCN spiked blood for each concentration above 58 µg/L. These
higher concentrations produced signal recoveries of ~92-99% of the “total CN”, generally
confirming the efficiency and consistency of the KMnO4 oxidation of SCN to CN. The
disparity between the sum of signals of the individually spiked blood and the CN/SCN
spiked blood at 58 µg/L is because the signal produced from analysis of the lowest
concentration CN-spiked blood standard (58 µg/L/1 µM) was similar to signals produced
from non-spiked (i.e., blank) blood. The minimal signal produced from the smallest
concentration of CN was likely due to reaction of CN- with electrophilic centers in the
blood. CN- is a strong nucleophile and will bind to many components of blood. These
binding sites are relatively plentiful for lower concentrations of CN but become less
available as the amount of CN increases. Even though total CN was not measured over the
entire concentration range tested, the sensor was capable of analyzing total CN when high
concentrations of cyanide were present, which is likely to occur in the early stages
following CN exposure. Considering the results in Figure 2, the sensor is able to detect
both CN and SCN such that at times immediately following CN exposure, where high
blood CN concentration and low SCN concentrations are present, the sensor will still allow
verification of cyanide-caught fish. After some time, when some of the CN has been
converted to SCN, the sensor will detect both these analytes. At longer times following
exposure, CN concentrations will be low and likely undetectable by the sensor, but SCN
concentrations will be elevated, allowing verification of CN-caught fish. Therefore, the
sensor should be able to determine CN-caught fish soon after capture and during later time
periods following CN exposure, until SCN concentrations fall below the LOD of the
sensor.
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Figure 4.2. Bar graph showing the comparison of the sum of blank-corrected signals of the
individually spiked CN and SCN samples (CN+SCN (individually spiked sample), in blue)
to the signal of the sample containing both CN and SCN spiked together (CN-SCN spiked
sample, in orange).

4.3.2. Background Concentration of SCN in Salmon Blood
Endogenous concentrations of SCN have been previously found in fish blood
(Table 1.1). When performing preliminary evaluation of calibration curves in salmon blood
for the current study, non-zero intercepts, indicative of the presence of SCN in non-spiked
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blood, were observed. In order to quantify the endogenous SCN in the salmon blood used
in this study, standard addition was carried out. Endogenous SCN concentrations were
analyzed over three days, producing concentrations ranging from 0.5-1.5 µM (29-87 µg/L)
with a mean of 1 µM (58±29 µg/L).
4.3.3. SCN Sensor Method Validation
Calibration curves were initially constructed within the concentration range of 0.320 μM (17.4-1160 µg/L). Based on the accuracy and precision criteria, the calibrators 0.3,
0.5, and 20 μM (17.4, 29, and 1160 µg/L) fell outside the entire linear range. Therefore,
the linear range of the method was 58 µg/L (LLOQ) to 580 µg/L (ULOQ) as best described
by non-weighted linear regression. All the calibration curves were stable over three days
of validation, as determined by consistency of their slopes (Table 3), producing an excellent
fit of the calibrators over the entire linear range with PRA values ≥ 93% and an average R2
value of 0.9846. The LOD of the current method was 0.5 μM (29 µg/L) in fish blood as
defined by the lowest concentration of SCN that produced a signal equal to the summation
of the mean blank signal and 3 times the standard deviation of the blank.

Table 4.2. Linear equations, coeﬃcients of determination (R2), and percent residual
accuracy (PRA) for calibration curves created over 3 separate days.
Day

Equation

R2

PRA (%)

1

y = 1.291x + 216

0.9865

94

2

y = 1.297x + 156

0.9797

93

3

y = 1.301x + 163

0.9885

95
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Table 4 shows the accuracy and precision of the method as evaluated by
quintuplicate analysis of low, medium and high QCs on three different days. The precision
and accuracy determined from each day’s analysis (intraassay) ranged from 4.7 to 15.1%
RSD and 100±19.7% for precision and accuracy, respectively. The precision and accuracy
calculated from comparison of the data gathered over 3 separate days (interassay) were
17.9% RSD and 100±6.9% for precision and accuracy, respectively. Both the intraassay
and interassay accuracy and precision of the sensor found from the 3-day validation meet
the accuracy and precision inclusion criteria of 100±20% and ≤ 20% RSD.

Table 4.3. The intra- and inter-assay accuracy and precision of SCN analysis from spiked
fish blood
Intraassay
Conc

Interassay

Accuracy (%)

Precision (%RSD)
Accuracy Precision

(µM)

Day
Day 1

a

Day 2

Day 3

100±2.1

Day

Day 1

(%)a

(%RSD)a

2

3

15.1

11.8

14.6

100±1.0

<17.9

2.0

100±3.2 100±8.2

4.0

100±2.8 100±19.7 100±0.9

8.6

5.5

5.5

100±6.9

<9.5

7.0

100±0.9 100±3.4

10.5

9.6

4.7

100±3.1

<9.0

100±3.1

Aggregate of three days of QC method validation (N = 15)
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4.3.4. Application of the Method
The validated method was used to analyze SCN from the blood of marine fish (A.
clarkii, commonly known as clownfish) exposed to CN. The concentrations of SCN
obtained from the blood of CN-exposed fish (N = 3) were each well above the LLOQ
(159.1, 176.4 and 183.2 µg/L; average = 172.9±14.0 µg/L). The endogenous SCN
concentration was above the LOD but below the LLOQ, so it could not be quantified, but
appeared to be near the LOD (29 µg/L). The amount of blood available precluded the use
of standard addition to quantify the concentration of SCN in the non-CN-exposed fish. The
ability of the sensor to differentiate between CN-exposed and non-exposed fish supports
the capability of the SCN sensor to determine CN-caught fish.
4.4. Conclusions
Considering the danger CN-fishing poses to aquatic ecosystems, a rapid and field
portable sensor was developed to analyze the major CN metabolite, SCN, in fish blood.
This method features simple sample preparation, short analysis time (<60 s), small sample
volume requirements (25 µL), minimal required expertise to operate and is fully field
portable. The accuracy and precision of the method were acceptable, and the method
produced an LOD of 29 µg/L, below endogenous SCN concentrations found for most fish
species studied. The method was found to detect both CN and SCN in fish blood and was
successfully applied to quantitate SCN from the blood of fish exposed to CN. The current
method is a promising technology that could be used by various stakeholders involve in
fighting the practice of CN-fishing to monitor the practice in the field.
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Chapter 5. Conclusions, Broader Impacts, and Future Work
5.1 Conclusions
A simple, direct, and rapid novel HPLC-MS/MS method was developed for
analysis of TRPA1 antagonist A-967079 from plasma. The method was successfully
applied to evaluate the pharmacokinetics in A-967079 from plasma of treated animals. A
novel cyanide metabolite ATOEA, was discovered based on the metabolism of cyanide by
glutathione. The kinetics of ATOEA in CN-exposed animals confirms that it is a promising
biomarker to confirm cyanide exposure. A field portable fluorescent detection method was
developed to determine the CN metabolite thiocyanate, from fish blood. The method
features a short analysis time, an excellent accuracy and precision and was successfully
applied to analyze SCN from fish exposed to CN to verify CN-fishing.
5.2 Broader Impacts
Toxic inhaled hazards are useful in industrial manufacturing but pose major global
threat to humanity. Researching to better understand the toxicological behavior of these
hazards, development of technologies to determine their exposure, and development of
effective therapeutic agents are crucial to defend against the effects of TIHs exposure. The
novel method for the analysis of A-967079 presented here will allow for further
development of A-967079 as a promising therapeutic agent against the noxious effect of
TIHs exposure. In addition, the discovery of a novel cyanide metabolite ATOEA, has
provided additional insight into the metabolism of cyanide and can serve as a potential
marker to confirm CN exposure. Furthermore, rapid, easy and field portable method
developed for SCN analysis in fish blood will allow government, aquarium trade and food
agencies to monitor the CN-fishing and enforce laws to curb this illegal practice. Overall,
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the work presented here will contribute to the development methods to confirm exposure
to TIH and the development of therapeutic agents for TIH.
5.3 Future Work
Future work should include the application of the A967079 developed method to
expand the pharmacokinetic studies of A967079 in many animal models before extending
to human studies for full development of A967079 as therapeutics. The toxicokinetics of
ATOEA in other animal models should be evaluated to better understand the kinetics of
ATOEA, and also future work should identify degradation product(s) of ATOEA in
biological samples and evaluate the stability of the product(s). Lastly, the thiocyanate
method should be apply to analyze fish blood samples from areas where CN-fishing is
practice to further evaluate the technology.
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